Skip to main content
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2023 Dec 29;131(12):127023. doi: 10.1289/EHP11329

Immunotoxicity Evaluation of Trihalophenolic Disinfection By-Products in Mouse and Human Mononuclear Macrophage Systems: The Role of RNA Epitranscriptomic Modification in Mammalian Immunity

Min Qin 1,4,*, Linyuan Huang 3,5,*, Meishuang Li 2,*, Tianye Shao 1, Jun Zhang 3, Xiaoqin Jiang 2, Chenlu Shao 1, Chengsi Zhao 1, Yang Pan 2, Qing Zhou 2,, Yong Wang 1, Xiao-Min Liu 3,, Jingfan Qiu 1,
PMCID: PMC10756339  PMID: 38157273

Abstract

Background:

2,4,6-Trichlorophenol (TCP), 2,4,6-tribromophenol (TBP) and 2,4,6-triiodophenol (TIP) are three widely detected trihalophenolic disinfection by-products (DBPs). Previous studies have mainly focused on the carcinogenic risk and developmental toxicity of 2,4,6-trihalophenols. Very little is known about their immunotoxicity in mammals.

Objectives:

We investigated the effects of 2,4,6-trihalophenols on mammalian immunity using a mouse macrophage model infected with bacteria or intracellular parasites and aimed to elucidate the underlying mechanisms from an epitranscriptomic perspective. The identified mechanisms were further validated in human peripheral blood mononuclear cells (PBMCs).

Methods:

The mouse macrophage cell line RAW264.7 and primary mouse peritoneal macrophages were exposed to different concentrations of TCP, TBP, and TIP. The pro-inflammatory marker Ly6C, the survival of the bacterium Escherichia coli (E. coli), and the parasite burden of Toxoplasma gondii (T. gondii) were assessed. Furthermore, the global gene expression profiling of macrophages following exposure to 2,4,6-trihalophenols was obtained through RNA-sequencing (RNA-seq). The effects of 2,4,6-trihalophenols on RNA N6-methyladenosine (m6A) methyltransferases and total RNA m6A levels were evaluated using Western blotting and dot blot, respectively. Transcriptome-wide m6A methylome was analyzed by m6A-seq. In addition, expression of m6A regulators and total RNA m6A levels in human PBMCs exposed to 2,4,6-trihalophenols were detected using quantitative reverse transcriptase polymerase chain reaction and dot blot, respectively.

Results:

Mouse macrophages exposed to TCP, TBP, or TIP had lower expression of the pro-inflammatory marker Ly6C, with a greater difference from control observed for TIP-exposed cells. Consistently, macrophages exposed to such DBPs, especially TIP, were susceptible to infection with the bacterium E. coli and the intracellular parasite T. gondii, indicating a compromised ability of macrophages to defend against pathogens. Intriguingly, macrophages exposed to TIP had significantly greater m6A levels, which correlated with the greater expression levels of m6A methyltransferases. Macrophages exposed to each of the three 2,4,6-trihalophenols exhibited transcriptome-wide redistribution of m6A. In particular, the m6A peaks in genes associated with immune-related pathways were altered after exposure. In addition, differences in m6A were also observed in human PBMCs after exposure to 2,4,6-trihalophenols.

Discussion:

These findings suggest that 2,4,6-trihalophenol exposure impaired the ability of macrophages to defend against pathogens. This response might be associated with notable differences in m6A after exposure. To the best of our knowledge, this study presents the first m6A landscape across the transcriptome of immune cells exposed to pollutants. However, significant challenges remain in elucidating the mechanisms by which m6A mediates immune dysregulation in infected macrophages after 2,4,6-trihalophenol exposure. https://doi.org/10.1289/EHP11329

Introduction

Disinfection is indispensable in water treatment to inactivate harmful pathogens and protect public health. However, during the disinfection process, disinfectants, such as chlorine and monochloramine, can react with natural organic matter and halides to form numerous halogenated disinfection by-products (DBPs).13 Ever since the first identification of 2,4,6-trihalophenols, including 2,4,6-trichlorophenol (TCP), 2,4,6-tribromophenol (TBP), and 2,4,6-triiodophenol (TIP), with a powerful precursor ion scan method in chlorinated drinking water,1,4,5 studies have shown that aromatic DBPs are the non-negligible contributors to total organic halogen and in vivo (in marine polychaete Platynereis dumerilii embryos and zebrafish embryos and zebrafish embryos) toxicity of chlorinated drinking water.68 The concentrations of TCP, TBP, and TIP in drinking water treatment plants from the Yangtze River Delta Region of China and the simulated drinking water samples were up to 215, 57, and 33 ng/L, respectively.2,3 2,4,6-Trihalophenols can enter the human body through water intake and dermal contact9,10 and have been detected in human urine11 and serum.12 TCP, TBP, and TIP have been associated with a number of adverse effects, such as carcinogenicity (using the general population and mouse and rat models),13 genotoxicity [using in vitro V79 Chinese hamster cells14 and human peripheral blood mononuclear cells (PBMCs)15], and developmental toxicity (using in vitro human extended pluripotent cells16 and the marine polychaete Platynereis dumerilii17).18 Therein, TCP and other polychlorophenols (combined exposures) were classified as possible human carcinogens (Group 2B) by the World Health Organization’s International Agency for Research on Cancer in 1999.13 TBP was reported to cause DNA damage in human PBMCs using an in vitro assay.15 Recent studies using the marine polychaete worm17 and human16 and mouse19 cell line models have indicated that TIP is more developmentally toxic and cytotoxic compared with its chlorinated and brominated analogs. However, previous studies mainly focused on the carcinogenic, developmental, and mutagenic toxicity of 2,4,6-trihalophenols. Very little is known about their immunotoxicity in mammals.

The macrophage is a type of vital immune cell that plays essential roles in maintaining immune balance and organizing defense against infection.20 Sensing pathogen attack, macrophages can directly eliminate invading pathogens and induce a series of immune reactions.21 Our previous study found that treatment with 200μM TIP or TBP remarkably induced M2-dominant polarization of macrophages, whereas treatment with TCP triggered an M1-dominant polarization of macrophages.19 A growing body of evidence has suggested that macrophage dysfunction is associated with various diseases.20 For example, the unexpected M2 polarization of macrophages might contribute to uncontrolled infection as explored in mice.22 Therefore, evaluating the effects of three 2,4,6-trihalophenols on macrophage-mediated resistance to infection could facilitate our understanding of the complex host–pathogen–environment interactions.

In recent years, emerging in vitro evidence has suggested that RNA N6-methyladenosine (m6A) modification is involved in anti-infectious immunity and could regulate the function of macrophages.2327 Methylation of adenosine at the N6 position (m6A) is the most abundant chemical modification on eukaryotic mRNA.28,29 In eukaryotic species, m6A modification is regulated by three types of functional proteins, including methyltransferases, demethylases, and m6A binding proteins.30 m6A modification is catalyzed by a multicomponent methyltransferase complex containing methyltransferase-like 3 (METTL3), METTL14, and Wilms tumor 1 associated protein (WTAP).31 Demethylases, including fat mass and obesity associated (FTO) and alkylation repair homolog 5 (ALKBH5), are responsible for removing m6A from mRNA.32,33 In addition, YT521-B homology domain family 1 (YTHDF1), YTHDF2, YTHDF3, YT521-B homology domain containing 1 (YTHDC1), and YTHDC2 are m6A binding proteins, which directly recognize this mark and modulate the splicing, translation, and stability of mRNA.34 m6A has been shown to be responsive to cellular stress conditions, such as heat in bovine mammary epithelial cells35 and nutrition deprivation in neuroblastoma cells,36 and to play a functional role in the stress response.37 Studies in recent years have shown exposure to environmental stressors, such as air pollution38 and cigarette smoke,39 to be associated with global m6A changes in lung epithelial cells and peripheral blood, respectively, from participants in the Beijing Truck Diver Air Pollution Study. Although research on m6A modification is in its infancy in the field of environmental health, lacking studies with transcript-level m6A, its importance to macrophage polarization23 and immune response against infection24,26,27 is indisputable. In light of these findings, we predict that m6A modification might be associated with the immunotoxic effects of 2,4,6-trihalophenols on macrophages.

In the present study, we evaluated the immunotoxicity and immunomodulatory effects of three 2,4,6-trihalophenols on macrophages. Escherichia coli (E. coli) and Toxoplasma gondii (T. gondii) infection models were employed to investigate macrophage-mediated resistance to infection after TCP, TBP, and TIP treatment. In addition, we mapped and compared the m6A methylomes of macrophages in response to TCP, TBP, and TIP exposure. The underlying mechanism of 2,4,6-trihalophenol-induced immunotoxicity was explored from an epitranscriptomic perspective. Finally, the toxicity-related alteration of m6A was validated in human PBMCs.

Methods

Study Design

The prespecified objective of the present study was to investigate the immunotoxicity and immunomodulatory effects of three 2,4,6-trihalophenols (TCP, TBP, and TIP) on mammalian mononuclear macrophage systems and to reveal the underlying mechanism. For ethical reasons, the mouse macrophage cell line RAW264.7 was mainly employed to investigate the immunotoxicity and immunomodulatory effects of 2,4,6-trihalophenols (Figure S1). Using the RAW264.7 cell line, the cell viability and expression of the macrophage pro-inflammatory marker Ly6C was assessed after 2,4,6-trihalophenol exposure. RAW264.7 cell-mediated resistance to infection after 2,4,6-trihalophenol exposure was evaluated using the bacterium E. coli, as well as the parasite T. gondii, infection models. The transcriptomes and m6A methylomes of RAW264.7 cells in response to TCP, TBP, and TIP exposure were obtained by RNA- uencing (RNA-seq) and m6A-seq. Effects of 2,4,6-trihalophenols on m6A regulators and total RNA m6A levels in RAW264.7 cells were evaluated using quantitative reverse transcriptase polymerase chain reaction (qRT-PCR), Western blotting, and dot blot. We also analyzed the m6A modification of immune-related genes using m6A immunoprecipitation qPCR (m6A-IP-qPCR) on RAW264.7 cells that were challenged with parasite T. gondii infection. To further verify the effects of 2,4,6-trihalophenols on m6A methyltransferases, mouse peritoneal macrophages were employed. Furthermore, we evaluated the effects of 2,4,6-trihalophenols on human PBMCs. After exposure to 2,4,6-trihalophenols, expression of m6A regulators and total RNA m6A levels in human PBMCs were respectively detected using qRT-PCR and dot blot. According to the results of the Cell Counting Kit 8 (CCK8; Cat. #A311-01, Vazyme) assay, the concentrations used in this study were 50, 100, and 200μM, which are higher than the environmental concentrations of 2,4,6-trihalophenols. We intentionally used these higher concentrations for better observation of the acute effects of 2,4,6-trihalophenols.

Chemicals

The TCP (Cat. #T0390), TBP (Cat. #T0349), and TIP (Cat. #T0452) used in this study were purchased from TCI Shanghai. Purity of TCP, TBP, and TIP was >97.0%, >98.0%, and >98.0%, respectively (Table S1). TCP, TBP, and TIP were dissolved in dimethyl sulfoxide (DMSO; Cat. #D2650, Sigma-Aldrich, purity 99.7%) to prepare a 400 mM stock solution for in vitro study. All stock solutions were stored at 20°C. Because the final concentration of DMSO in the cell culture medium was <0.1% (vol/vol), 0μM was used as a negative control for exposure experiments.

Animal Experiments and Isolation of Mouse Peritoneal Macrophages

C57BL/6 mice (6–8 wk old and weighing 1820g) were purchased from the Animal Core Facility of Nanjing Medical University (Nanjing, China). This study was approved by the Animal Ethics Committee of Nanjing Medical University, and mouse experiments were performed in accordance with the approved guidelines (permit no.: NJMU/IACUC-2007024). Forty mice were euthanized by carbon dioxide (CO2) inhalation. Each mouse was injected with 7mL of phosphate buffered saline (PBS) with 1% fetal bovine serum (FBS; Cat. #S711-001S, Lonsera) into the peritoneal cavity after euthanasia. After gently massaging the mouse’s abdomen, as much as possible of the injected PBS was collected using a 5-mL syringe. Then, the cells were combined and centrifuged at 500g for 5 min at 4°C. The cells were counted by hemocytometer and cultured in 6-well culture plates (2×106 cells/well) in Dulbecco’s modified Eagle medium (DMEM; Cat. #C11995500BT, Gibco) containing 10% FBS (Cat. #S711-001S, Lonsera), 1% 100×penicillin and streptomycin (Cat. #15140122, Gibco). After adhering for 1 h, the peritoneal macrophages attached to the culture plates and nonadherent cells were washed off with PBS. Then, the mouse peritoneal macrophages were treated with 100μM TCP, TBP, or TIP for 24 h (3 wells per treatment, n=3 technical replicates).

Isolation of Human PBMCs

This study was approved by the ethics review board of Nanjing Medical University [permit no.: NJMU/(2021) 668]. Three healthy volunteers were male, 20–30 y of age, had never smoked or used illicit drugs. Blood samples were processed immediately after collection. First, 30mL of venous blood samples from the healthy volunteers were mixed with PBS in a 1:1 ratio. Then, Ficoll (Cat. #17144002, Cytiva) was added to the centrifuge tube. The diluted blood sample was carefully layered onto the Ficoll (4:3 vol ratio of diluted blood sample to Ficoll) and centrifuged at room temperature for 30 min at 400g with the brake off. The separated mononuclear cells were washed twice with at least three volumes of PBS and centrifuged at 300g for 10 min at room temperature. After that, isolated PBMCs were cultured in 6-well culture plates (1×106 cells/well) in DMEM (Cat. #C11995500BT, Gibco) containing 10% FBS (Cat. #S711-001S, Lonsera), 1% 100×penicillin and streptomycin (Cat. #15140122, Gibco). After 24 h cultivation, the isolated mononuclear cells were treated with 100μM TCP, TBP, or TIP for 24 h. PBMCs from the three donors served as three biological replicates (n=3 biological replicates).

Cell Culture of RAW264.7 Cells and 2,4,6-Trihalophenol Exposure

Mouse macrophage RAW264.7 cells were the kind gift of Z. Xu, Nanjing Medical University. The RAW264.7 cells were cultured in DMEM (Cat. #C11995500BT, Gibco) containing 10% FBS (Cat. #S711-001S, Lonsera), 1% 100×penicillin and streptomycin (Cat. #15140122, Gibco). Serial subculture dilution was performed when the cell confluence of RAW264.7 cells reached 70%–80%. The RAW264.7 cells were then cultured in 96-well culture plates (1×104 cells/well), 24-well culture plates (1×105 cells/well), or 6-well culture plates (5×105 cells/well). After adhering overnight, the RAW264.7 cells were treated for 24 h with different concentrations of TCP, TBP, and TIP ranging from 0 to 800μM (n=3 wells per treatment for CCK8 assay and flow cytometry).

CCK8 Assay

CCK8 cell counting kit (Cat. #A311-01, Vazyme) was used to detect the cell viability after TCP, TBP, or TIP exposure, following the manufacturer’s instructions. The RAW264.7 cells (1×104 cells/well) were seeded into 96-well culture plates and allowed to adhere overnight. Then different concentrations [0 (control), 50, 100, 200, 400, or 800μM] of TCP, TBP, and TIP were added into the 96-well culture plates and incubated with the RAW264.7 cells for 24 h (n=3 wells per treatment). Subsequently, the cell culture medium was replaced with fresh DMEM containing 10% CCK8 solution. After 1 h incubation, the absorbance at 450 nm was measured by a Synergy HT Microplate Reader (BioTek). The absorbance at 450 nm from each well represented the number of cells per well. The relative absorbance (relative cell viability) was calculated as follows: relative absorbance=[(experimental absorbancebackground absorbance)/(untreated control absorbancebackground absorbance)]. The concentration 0μM was employed as the untreated control. CCK8 assay was repeated twice with independent sample preparations.

Flow Cytometry

To evaluate the differences in the proportion of lymphocyte antigen 6 complex locus C positive [lymphocyte antigen 6 complex, locus C (Ly6C+)] macrophages, RAW264.7 cells were stimulated with TCP, TBP, or TIP [0 (control), 50, 100, or 200μM] for 24 h (n=3 wells per treatment). Then, the cells were collected and incubated with anti-mouse CD16/32 antibody (1:200 dilution; Cat. #156604, BioLegend) at 4°C for 15 min. Next, the cells were incubated with fluorescein isothiocyanate (FITC) antimouse F4/80 antibody (1:500 dilution; Cat. #123108, BioLegend), allophycocyanin (APC) antimouse CD11b antibody (1:100 dilution; Cat. #101212, BioLegend), and peridinin–chlorophyll–protein complex (PerCP)/Cyanine 5.5 antimouse Ly-6C antibody (1:150 dilution; Cat. #128012, BioLegend) in the dark at 4°C for 30 min. Then, the samples’ labels were detected by FACSVerse flow cytometer (BD Biosciences) and analyzed by FlowJo software (version 10.0.7; Tree Star).

Bacteria Culture

E. coli 8099 (CGMCC 1.3373) was purchased from Guangdong Huankai Microbial Sci. & Tech. Co., Ltd. The preparation of competent cells for transformation was performed by adopting the calcium chloride (CaCl2) method. One hundred nanograms of pEF 3-YFP-2 plasmids (Cat. #20106, Addgene), which contain the gene of enhanced yellow fluorescent protein (EYFP) and kanamycin-resistance gene (kanR), were added into 100μL of competent E. coli cells. The mixture was gently rotated and incubated on ice for 30 min. Then the mixture was bathed in water at 42°C for 90 s and quickly placed on ice for 1–2 min. Six hundred microliters of Luria-Bertani (LB) broth was added before 200 rpm shaking at 37°C for 1 h. Then 100μL of the cultures were spread on an LB agar plate (Cat. #HB0129, Hopebio) supplemented with 50μg/mL kanamycin (Cat. #K1030, Solarbio) and cultured overnight at 37°C. A single bacterial colony picked from the agar plate was inoculated to LB broth supplemented with 50μg/mL kanamycin. After overnight cultivation, the E. coli/pEF 3-YFP-2 cultures were centrifuged (3,000g, 10 min at room temperature), suspended in 20% glycerol, and then stored at 20°C. The stored E. coli/pEF 3-YFP-2 cells were added into 5mL of fresh LB broth supplemented with 50μg/mL kanamycin at a ratio of 1:100 (vol/vol), and was cultivated until OD600 reached 0.6–0.8 with shaking (200 rpm) at 37°C. To calculate bacterial concentration via the number of colony forming units (CFUs) per milliliter, the cultures were serially diluted 10-fold by sequential transfer of 100μL into 900μL of ultrapure sterile water. The last dilution of 1mL was separately spread out on three LB agar plates supplemented with 50μg/mL of kanamycin and cultured at 37°C overnight. Then three plates with colonies for each sample were taken for calculating CFUs. The same method was used in subsequent experiments to determine the number of E. coli/pEF 3-YFP-2.

Preparation of T. gondii Tachyzoites

Both T. gondii RH tachyzoites and green fluorescent protein (GFP)–expressing RH tachyzoites were the kind gifts of J. Shen, Anhui Medical University. They were preserved in liquid nitrogen. Human foreskin fibroblasts (HFFs) were also the kind gift of J. Shen and used to culture T. gondii tachyzoites. HFF cells were cultured in DMEM (Cat. #C11995500BT, Gibco) containing 10% FBS (Cat. #S711-001S, Lonsera), 1% 100×penicillin and streptomycin (Cat. #15140122, Gibco). When the confluence of HFF cells reached 80% in a 25-cm2 culture flask, 2.5×105 T. gondii RH tachyzoites or GFP-RH tachyzoites were added to the cell cultures and cultivated for 3–4 d at 37°C in 5% CO2. After observing the release of a large number of tachyzoites, the cells were scraped off from the culture flask. All cultures with tachyzoites were filtered through a 3-μm pore-sized track-etched membrane (Cat. #111112, Whatman). Then the filtrate containing the tachyzoites was saved for subsequent infection assay. Tachyzoites were counted with a hemocytometer under a Primovert microscope (Zeiss).

Macrophage Infection Assay

In the bacterium infection model, RAW264.7 cells were cultured in 24-well culture plates (1×105 cells/well) and allowed to adhere overnight. The RAW264.7 cells were incubated with TCP, TBP, and TIP at different concentrations (0, 50, or 100μM) for 24 h. After incubation, a well of untreated cells was detached with 0.25% trypsin-ethylenediaminetetraacetic acid (EDTA; Cat. #25200072, Gibco) to count the number of cells per well by hemocytometer. The number of E. coli/pEF 3-YFP-2 was calculated as aforementioned. Then, the cell cultures were rinsed with PBS three times and the medium was replaced with fresh DMEM containing 10% FBS, 50μg/mL kanamycin, and E. coli/pEF 3-YFP-2 at a multiplicity of infection (MOI) of 100 bacteria per cell (MOI of 100).40 After incubation in the incubator (37°C, 5% CO2) for 1.5 h, infected macrophage cultures were directly centrifuged at 3,000g for 10 min at room temperature to collect the total bacteria (n=3 biological replicates). To collect intracellular bacteria only (n=3 biological replicates), infected RAW264.7 cells, in culture plates, were washed with PBS three times before centrifugation. After centrifugation (3,000g, 10 min at room temperature), equivalent ultrapure sterile water was added for resuspension. Then, the bacterial suspensions were serially diluted and spread on kanamycin-resistant agar plates as mentioned above for quantifying surviving bacteria (in colony forming units per milliliter).

In the parasite infection model, RAW264.7 cells were pretreated with 50 or 100μM TCP, TBP, or TIP for 24 h (n=3 biological replicates, each with two technical replicates). The concentration 0μM was employed as the control (n=3 biological replicates, each with two technical replicates). Then the cells were infected with prepared T. gondii tachyzoites at an MOI of 1 in fresh medium for 24 h. The parasite burden of T. gondii in macrophages was calculated as the ratio of the mRNA levels of T. gondii internal transcribed spacer 1 (ITS1) gene to normalized RAW264.7 cell number, which was adjusted by the cell viability measured by CCK8 assay. The method to detect the mRNA levels of ITS1 is described below.

qRT-PCR

The mRNA levels of m6A methyltransferases, m6A demethylases, m6A binding proteins, T. gondii ITS1 gene, mouse tumor necrosis factor-alpha (Tnf-α), and eukaryotic translation initiation factor 2-alpha kinase 2 (Eif2ak2) genes were detected by qRT-PCR. Total RNA of RAW264.7 cells (with or without T. gondii infection), mouse peritoneal macrophages, and human PBMCs was extracted via TRIzol reagent (Cat. #15596018, Invitrogen). Total RNA was quantified using NanoDrop 2000 (Thermo Fisher Scientific). RNA purity was confirmed by determining the optical density 260/280 (OD260/OD280) absorption ratio. The ratio of OD260/OD280 of the extracted RNA ranged from 1.8 to 2.0. One microgram of total RNA for each sample was reverse-transcribed using HiScript III RT Supermix (Cat. #R323-01, Vazyme) in Veriti 96-Well Thermal Cycler (Thermo Fisher Scientific). Semiquantitative RT-PCR was carried out in a LightCycler 96 Instrument (Roche) containing complementary DNA (cDNA; 50 ng cDNA per 20μL of reaction), 10μM primer pairs, and SYBR qPCR Master Mix (Cat. #Q411-02, Vazyme). The reference gene of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used for normalization. The cycling conditions were as follows. The first step was pre-denaturation (1 cycle, 95°C for 30 s). The second step was two-step amplification (40 cycles, 95°C for 10 s and 60°C for 30 s). The third step was for the melting curve (1 cycle, 95°C for 15 s, 60°C for 60 s, and 95°C for 15 s). The primers were designed using the National Center for Biotechnology Information (NCBI) Primer–Basic Local Alignment Search Tool (BLAST) (https://www.ncbi.nlm.nih.gov/tools/primer-blast/). The sequences of the gene-specific primers used in this study are listed in Table S2.

Dot Blot

The m6A dot blot assay is a classic and relatively straightforward method to detect global m6A differences in total RNA.41 Total RNA from RAW264.7 cells and human PBMCs was extracted via TRIzol (Cat. #15596018, Invitrogen). Then the total RNA was diluted to 1,000, 800, 500, 400, 250, and 200 ng/μL, serially diluted, and spotted on a nylon membrane (Cat. #FFN13, Beyotime Biotechnology). The membrane was cross-linked at ultraviolet (UV) 254 nm, 0.12J/cm2. After UV cross-linking, the blotted membrane was blocked in PBS containing 0.1% Tween-20 (PBST; Cat. #30189328, Sinopharm Chemical Reagent Company) and 5% nonfat milk (Cat. #FD0080, FDbio Science) for 1 h at room temperature. The membrane was then incubated with anti-m6A antibody (1:1,000 dilution; Cat. #ab284130, Abcam) at 4°C overnight. The membrane was incubated with horseradish peroxidase (HRP)–conjugated antirabbit immunoglobulin G (IgG; 1:5,000 dilution; Cat. #7074, Cell Signaling Technology) at room temperature for 1 h and visualized by FDbio-Dura ECL Kit (Cat. #FD8020, FDbio Science). Dot blot analysis of RNA from RAW264.7 cells was performed three independent times (n=3 biological replicates).

Western Blotting

RAW264.7 cells were lysed using radioimmunoprecipitation assay (RIPA) lysis buffer (Cat. #20-188, Millipore) supplemented with protease and phosphatase inhibitor cocktail (Cat. #P1045, Beyotime Biotechnology), and phenylmethylsulfonyl fluoride (PMSF; Cat. #ST506, Beyotime Biotechnology). Lysates were centrifuged at 12,000g for 15 min at 4°C. The supernatant was then collected in a new Eppendorf tube. Protein concentrations were measured via bicinchoninic acid (BCA) assay (Cat. #PA115, TIANGEN) and equalized with PBS and sodium dodecyl sulfate and polyacrylamide gel electrophoresis (SDS-PAGE) sample loading buffer (Cat. #P0015L, Beyotime Biotechnology). After boiling for 10 min, an equal amount (20μg) of protein extracts was subjected to gels and separated by SDS-PAGE. Subsequently, the proteins were transferred onto a fitted polyvinylidene fluoride (PVDF) membrane (Cat. #ISEQ00010, Millipore), blocked with 5% nonfat milk in Tris-buffered saline with Tween-20 (TBST; Cat. #30189328, Sinopharm Chemical Reagent Company) for 2 h at room temperature and incubated with 1:1,000 diluted primary antibodies in TBST at 4°C overnight. For Western blotting, N6-mA Methyltransferase Antibody Sampler Kit (1:1,000 dilution for METTL3, METTL14, and WTAP; Cat. #69159) and GAPDH Rabbit mAb (1:1,000 dilution; Cat. #2118) were bought from Cell Signaling Technology. After incubation with secondary antibody HRP-conjugated antirabbit IgG (1:5,000 dilution; Cat. #7074, Cell Signaling Technology) at room temperature for 1 h, the membrane was visualized by FDbio-Dura ECL Kit (Cat. #FD8020, FDbio Science). Images were taken by ChemiDoc Touch Imaging System (Bio-Rad). Western blotting bands were quantified with Image Lab software (version 6.0; Bio-Rad). All the Western blotting experiments were performed three independent times (n=3 biological replicates).

RNA-Seq and m6A-Seq

RAW264.7 cells were treated with 100μM TCP, TBP, or TIP for 24 h (n=2 biological replicates). Total RNA was extracted using TRIzol (Cat. #15596018, Invitrogen). Poly(A) RNA was purified from no less than 50μg of total RNA using Dynabeads Oligo(dT)25 (Cat. #61005, Thermo Fisher Scientific) by two rounds of purification. Poly(A) RNA was fragmented at 94°C for 5 min in fragmentation buffer [10 mM Tris-hydrochloride (Tris-HCl), pH 7.0, 10 mM zinc chloride (ZnCl2)]. The reaction was stopped with 0.5M EDTA. RNA was precipitated using 3M sodium acetate, glycogen, and ethanol as referred to in previously published methods.42 The RNA was pelleted, washed, and resuspended in RNase-free water. A portion of RNA fragments served as the input control in RNA-seq. For m6A-seq, m6A-specific antibody (Cat. #202003, Synaptic Systems) was incubated with RNA fragments in 1×IP buffer [10 mM Tris-HCl, pH 7.4, 150 mM sodium chloride (NaCl), 0.1% Igepal CA-630] on a rotator for 2 h at 4°C. While the samples were incubated, Protein A/G beads (Cat. #20421, Thermo Fisher Scientific) were washed and blocked in IP buffer supplemented with bovine serum albumin (BSA) (0.5mg/mL) for 2 h. The RNA mixtures were then incubated with the previously blocked Protein A/G beads for another 2 h at 4°C. After that, the supernatant was discarded and the beads that were bonded with m6A-methylated RNA fragments were washed with IP buffer three times and then subjected to elution. In brief, the beads were eluted twice in 100μL of elution buffer [1×IP buffer containing 6.7 mM m6A 5′-monophosphate sodium salt (Cat. #sc-215524) bought from Santa Cruz Biotechnology] with head-over-tail rotation for 1 h at 4°C. Then the beads were spun down and carefully removed, retaining the supernatant. The desired m6A-enriched RNA fragments were retained in the supernatant. All the supernatants were combined, and RNA was concentrated by ethanol precipitation. The desired m6A-enriched RNA was used to construct a cDNA library in parallel with input control. The m6A-enriched RNA was reverse-transcribed into cDNA using SuperScript II reverse transcriptase (Cat. #18064071, Invitrogen). Next, E. coli DNA polymerase I (Cat. #M0209, NEB), RNase H (Cat. #M0297, NEB) and 2′-deoxyuridine 5′-triphosphate (dUTP) solution (Cat. #R0133, Thermo Fisher Scientific) were used to synthesize U-labeled second-stranded DNAs. Each strand’s blunt ends received an A-base addition so as to be ready for ligation to the indexed adapters. The fragments were ligated with dual-index adapters, and size selection was conducted with AMPure XP beads (Cat. #A63880; insert size: 180–220 bp). The U-labeled second-stranded DNAs were treated with the heat-labile uracil–DNA glycosylase (UDG) enzyme (Cat. #M0280, NEB), and the ligated products were amplified with PCR to create a sequencing library. The PCR conditions were as follows: initial denaturation at 95°C for 3 min; 8 cycles of denaturation at 98°C for 15 s, annealing at 60°C for 15 s, and extension at 72°C for 30 s; and then final extension at 72°C for 5 min. The library quality was assessed using an Agilent Bioanalyzer 2100 system. Last, we performed paired-end sequencing (PE150) on an Illumina Novaseq 6000 platform [sequencing primers: VAHTS i5 PCR Primer: 5′-AATGATACGGCGACCACCGAGATCTACAC(i5)ACACTCTTTCCCTACACGACGCTCTTCCGATC-s-T-3′; VAHTS i7 PCR Primer: 5′-CAAGCAGAAGACGGCATACGAGAT(i7)GTGACTGGAGTTCAGACGTGTGCTCTTCCGATC-s-T-3′]. All the sequencing experiments were performed with two biological replicates (n=2).

Quality control of m6A-seq data was performed using FastQC (https://www.bioinformatics.babraham.ac.uk/projects/fastqc; version 0.11.9). Low-quality bases and adapter contamination were deleted by Trim Galore (https://www.bioinformatics.babraham.ac.uk/projects/trim_galore; version 0.6.5) with Q20 and Q30 as sequencing quality scores. Mouse rRNA sequences from NCBI (NR_046233.2) were downloaded. The sequence reads were aligned to the rRNA reference using Bowtie (http://bowtie-bio.sourceforge.net/index.shtml; version 1.0.0) and the rRNA alignments were discarded. Unmapped reads were aligned to the GRCm38 reference genome using HISAT2 (http://daehwankimlab.github.io/hisat2) with default parameters. Peaks were identified using R software (version 3.4.4; R Development Core Team) by R package exomePeak (https://www.bioconductor.org/packages/3.3/bioc/html/exomePeak.html) and annotated by ANNOVAR (http://www.openbioinformatics.org/annovar/). The distribution of m6A was plotted by R package Guitar (version 2.6.0).43 Motif finding on m6A was done using HOMER (http://homer.ucsd.edu/homer; version 4.11) findMotifs.pl program.

Reads mapping and processing of RNA-seq data were performed as described for m6A-seq data above. StringTie (https://ccb.jhu.edu/software/stringtie) was used to calculate the number of reads mapped to each gene. R package EdgeR (version 3.3.2)44 was used for differential expression analysis. Genes with |log2Fold difference |1 and false discovery rate (FDR) <0.05 were defined as differentially expressed genes (DEGs). The raw RNA-seq and m6A-seq data have been deposited in the Gene Expression Omnibus (GEO) database under accession number GSE223045. Bioinformatic analyses were performed using the OmicStudio tools available at https://www.omicstudio.cn/tool.

m6A-IP-qPCR on RNA Extracted from T. gondii-Infected RAW264.7 Cells

RAW264.7 cells were cultured in 10-cm dishes (3×106 cells/dish). After adhering overnight, the RAW264.7 cells were pretreated with 100μM TCP, TBP, or TIP for 24 h. Then, the treated cells were rinsed, replenished with normal culture medium, and infected with T. gondii at an MOI of 1 for another 24 h. The supernatant was discarded and the cells were collected for RNA extraction with TRIzol (Cat. #15596018, Invitrogen). RNA from different batches of cells was pooled to perform the m6A-IP-qPCR assay (n=2 biological replicates). Total RNA was fragmented and immunoprecipitated with m6A antibody as described above in m6A-seq.42 The untreated fragmented RNA served as input control. Then, the m6A-enriched RNA fragments and input control were used to synthesize the first strand cDNA for qRT-PCR analysis as mentioned above. Primers targeting m6A-enriched regions of Tnf-α and Eif2ak2 were designed based on up- and downstream sequences of predicted m6A sites (Table S2).

Statistical Analyses

Statistical analyses were mainly done using SPSS software (version 17.0; IBM) and GraphPad Prism (version 8.0.1; GraphPad). Multiple comparisons were performed using one-way analysis of variance (ANOVA) followed by the Tukey post hoc test. Unpaired Student’s t-test was conducted for two-group comparison. Statistical significance was set at p<0.05. The corresponding numeric data for all figures are provided in the Supplemental Excel Files.

Results

Cell Viability of Mouse Macrophages after 2,4,6-Trihalophenol Exposure

The CCK8 assay was employed to measure the cell viability of mouse macrophage RAW264.7 cells after exposure to TCP, TBP, and TIP. The RAW264.7 cells were treated with TCP, TBP, and TIP over a range of concentrations [0 (control), 50, 100, 200, 400, or 800μM] for 24 h. From the OD values of the CCK8 assay, there was a downward trend of cell survival rate with increasing concentration of 2,4,6-trihalophenols, especially at high concentrations (Figure S2). For TCP, the cell survival rate was significantly lower at concentrations of 400 and 800μM (p<0.001). For TBP, the cell survival rate was significantly lower at concentrations of 200, 400, and 800μM (p<0.001). For TIP, statistically significant differences in cell survival rate were observed at concentrations of 50μM (p<0.05), 100μM (p<0.01), and 200, 400, and 800μM (p<0.001).

Expression of Ly6C on Macrophages

We stimulated RAW264.7 cells with different concentrations [0 (control), 50, 100, or 200μM] of all three 2,4,6-trihalophenols. The expression of Ly6C on macrophages was measured by flow cytometry. The percentages of Ly6C+ cells in the TBP and TIP groups were gradually less with increasing concentrations (p<0.01 for the 50 and 100μM TBP groups, p<0.001 for the 200μM TBP group and all the TIP groups; Figure 1A,B). The percentages of Ly6C+ cells were also lower after 100 and 200μM TCP exposure (p<0.05 for 100μM, p<0.001 for 200μM). The difference in Ly6C median fluorescence intensity (MFI) was generally consistent with that of Ly6C+ cell percentage. Ly6C MFI was inversely proportional to the concentration of TCP, TBP, and TIP (Figure 1C). The rank order of potency for inhibiting Ly6C expression was TIP>TBP>TCP.

Figure 1.

Figure 1A is a set of twelve flow cytometry analysis plots. On the left, the four plots are titled 2,4,6-Trichlorophenol, plotting S S C (left y-axis) and 0 micromolar, 50 micromolar, 100 micromolar, and 200 micromolar (right y-axis) across lymphocyte antigen 6 complex locus C (F 4 per 80 positive C D 11 lowercase b positive gated) (x-axis) for 7.58 percent, 7.11 percent, 6.58 percent, and 2.04 percent. At the center, the four plots are titled 2,4,6-Tribromophenol, plotting S S C (left y-axis) and 0 micromolar, 50 micromolar, 100 micromolar, and 200 micromolar (right y-axis) across lymphocyte antigen 6 complex locus C (F 4 per 80 positive C D 11 lowercase b positive gated) (x-axis) for 9.88 percent, 5.61 percent, 4.28 percent, and 2.52 percent. On the right, the four plots are titled 2,4,6-Triiodophenol, plotting S S C (left y-axis) and 0 micromolar, 50 micromolar, 100 micromolar, and 200 micromolar (right y-axis) across lymphocyte antigen 6 complex locus C (F 4 per 80 positive C D 11 lowercase b positive gated) (x-axis) for 8.58 percent, 3.30 percent, 2.07 percent, and 1.22 percent. Figures 1B and 1C are bar graphs, plotting percentage of lymphocyte antigen 6 complex locus C positive cells in F 4 per 80 positive C D 11 lowercase b positive gated R A W 264.7 cells (percentage), ranging from 0 to 15 in increments of 5 and lymphocyte antigen 6 complex locus C median fluorescence intensity, ranging from 0 to 250 in increments of 50 (y-axis) across 2,4,6-trichlorophenol, 2,4,6-tribromophenol, 2,4,6-triiodophenol (x-axis) for 0 micromolar, 50 micromolar, 100 micromolar, and 200 micromolar.

The expression of Ly6C on mouse macrophages after exposure to TCP, TBP, and TIP. (A) The expression of Ly6C on RAW264.7 macrophages (F4/80+CD11b+ gated cells) was evaluated by flow cytometry. One representative of three independent experiments is shown. (B) The percentage of Ly6C+ cells in F4/80+CD11b+ gated RAW264.7 cells. Data were analyzed using FlowJo software and are shown as mean±SD (n=3 technical replicates). Statistical significance was determined using one-way ANOVA with the Tukey post hoc test. *p<0.05, **p<0.01, ***p<0.001. The corresponding data are presented in Excel Table S1. (C) MFI of Ly6C expression on RAW264.7 macrophages. Data were analyzed using FlowJo software and are shown as mean±SD (n=3 technical replicates). Statistical significance was determined using one-way ANOVA with the Tukey post hoc test. *p<0.05, ***p<0.001. The corresponding data are presented in Excel Table S2. Note: ANOVA, analysis of variance; MFI, median fluorescence intensity; SD, standard deviation; SSC, side scatter; TBP, 2,4,6-tribromophenol; TCP, 2,4,6-trichlorophenol; TIP, 2,4,6-triiodophenol.

Mouse Macrophage-Mediated Resistance to Infection

E. coli/pEF 3-YFP-2 strain, which expressed YFP and was kanamycin-resistant, was used to construct the bacterial infection model. The RAW264.7 cells were pretreated with different concentrations of TCP, TBP, and TIP. Then the RAW264.7 cells were washed and infected with E. coli/pEF 3-YFP-2 at an MOI of 100. Compared with the control group, the number of surviving E. coli inside the infected macrophages was significantly greater in the 50 and 100μM TIP-pretreated groups (p<0.01; Figure 2A). Meanwhile, E. coli CFU was not significantly different between the control group and the TCP- or TBP-pretreated groups at the concentration of 100μM (p=0.295 for TCP, p=0.165 for TBP), or even lower in the 50μM TCP-pretreated group (p=0.009). It is known that in addition to phagocytosis, macrophages can also kill bacteria by secreting inflammation cytokines. Therefore, we further analyzed the total surviving bacteria in the cell culture, both inside and outside RAW264.7 cells. The number of total surviving E. coli was significantly greater after exposure to 50 and 100μM TBP and TIP, whereas TCP had no statistically significant effect on the number of total surviving bacteria (Figure 2B).

Figure 2.

Figures 2A and 2B are bar graphs. Figure 2A plots Intracellular surviving E.coli (colony forming units per milliliter), ranging as 0, 2 times 10 begin superscript 6 end superscript, 4 times 10 begin superscript 6 end superscript, 6 times 10 begin superscript 6 end superscript. Figure 2B plots Total surviving E.coli (colony forming units per milliliter), ranging as 0, 5 times 10 begin superscript 6 end superscript, 1 times 10 begin superscript 7 end superscript, 1.5 times 10 begin superscript 7 end superscript, 2 times 10 begin superscript 7 end superscript (y-axis) across 2,4,6-trichlorophenol, 2,4,6-tribromophenol, 2,4,6-triiodophenol (x-axis) for 0 micromolar, 50 micromolar, 100 micromolar. Figures 2C and 2D are bar graphs, plotting fold difference of parasite burden (versus control), ranging from 0 to 4 in unit increments and 0.0 to 2.5 in increments of 0.5 (y-axis) across 2,4,6-trichlorophenol, 2,4,6-tribromophenol, 2,4,6-triiodophenol (x-axis) for 2,4,6-trichlorophenol, 2,4,6-tribromophenol, 2,4,6-triiodophenol.

Effects of 2,4,6-trihalophenols on phagocytosis and pathogen clearance of mouse macrophages. (A) Surviving bacteria inside TCP-, TBP-, or TIP-pretreated RAW264.7 cells. RAW264.7 cells were pretreated with 0, 50 or 100μM 2,4,6-trihalophenol (TCP, TBP, or TIP) for 24 h. Then RAW264.7 cells were washed with PBS and infected with E. coli/pEF 3-YFP-2 at an MOI of 100 for 1.5 h. The number of surviving bacteria inside RAW264.7 cells was counted as CFU/mL. Data are represented as mean±SD (n=3 biological replicates). Data were analyzed by one-way ANOVA with the Tukey post hoc test. **P<0.01. The corresponding data are presented in Excel Table S3. (B) Total surviving bacteria in RAW264.7 cultures pretreated with TCP, TBP, or TIP. RAW264.7 cells were pretreated with 0, 50 or 100μM 2,4,6-trihalophenol (TCP, TBP, or TIP) for 24 h. Then RAW264.7 cells were washed with PBS and infected with E. coli/pEF 3-YFP-2 at an MOI of 100 for 1.5 h. The number of total surviving bacteria was counted as CFU/mL. Data are represented as mean±SD (n=3 biological replicates). Data were analyzed by one-way ANOVA with the Tukey post hoc test. *p<0.05, **p<0.01, ***p<0.001. The corresponding data are presented in Excel Table S4. (C,D) Parasite burden of intracellular parasite T. gondii in macrophages after exposure to TCP, TBP, or TIP. RAW264.7 cells were seeded at the same cell number and pretreated with 50μM (C) or 100μM (D) 2,4,6-trihalophenol (TCP, TBP, or TIP) for 24 h. Then RAW264.7 cells were infected with T. gondii in fresh medium for another 24 h. The parasite burden of T. gondii in macrophages was calculated as the ratio of the mRNA levels of the T. gondii ITS1 gene to normalized RAW264.7 cell number, which was adjusted by cell viability measured by CCK8 (Figure S2). Results are shown as fold differences compared with the control group (0μM). 1=no difference. Data are represented as mean±SD (n=3 biological replicates, each with two technical replicates). Data were analyzed by one-way ANOVA with the Tukey post hoc test. *p<0.05, ***p<0.001. The corresponding data are summarized in Excel Table S5. Note: ANOVA, analysis of variance; CCK8, Cell Counting Kit 8; CFU, colony forming units; MOI, multiplicity of infection; PBS, phosphate buffer saline; SD, standard deviation; TBP, 2,4,6-tribromophenol; TCP, 2,4,6-trichlorophenol; TIP, 2,4,6-triiodophenol.

Moreover, the intracellular parasite T. gondii was used to construct the parasite infection model. RAW264.7 cells were pretreated with 50 and 100μM TCP, TBP, or TIP for 24 h. No significant difference in the parasite burden of T. gondii was observed between the 50μM TCP-exposure group and the control group (Figure 2C; Figure S3). However, macrophages exposed to 50μM TBP and TIP had about 2- and 3-fold greater parasite burden, respectively (p<0.05 for TBP, p<0.001 for TIP). Perhaps owing to the toxicity of 2,4,6-trihalophenols to T. gondii, macrophages exposed to 100μM TIP had only 1.7-fold greater parasite burden (p<0.05), whereas there were no statistically significant differences in the parasite burden in the 100μM TCP- or TBP-pretreated groups (Figure 2D).

Global Gene Expression Profiling of Macrophages

To thoroughly evaluate the effects of 2,4,6-trihalophenols on macrophages, we performed global gene expression profiling by RNA-seq (Tables S3 and S4, Figure S4). We identified DEGs (|log2Fold difference |1 and FDR <0.05) in the exposure groups. After TCP, TBP, and TIP exposure, a total of 3,069, 608, and 3,894 genes were respectively up-regulated. Meanwhile, TCP, TBP, and TIP exposure also respectively down-regulated 547, 4,447, and 929 genes of macrophages (Figure 3A). For TCP and TIP, the number of up-regulated DEGs was greater than that of down-regulated DEGs. Interestingly, TIP exposure was associated with more up-regulated DEGs than its chlorinated and brominated analogs.

Figure 3.

Figure 3A is a set of two Venn diagrams. On the left, the Venn diagram is titled Differential expressed genes (up-regulated) and displays three circles: The circle on the top-left is labeled 2,4,6-tribromophenol, the circle on the top-right is labeled 2,4,6-triiodophenol, the circle at the bottom is labeled 2,4,6-trichlorophenol. The top-left circle displays the following information: 465, 42, 33, 68; the top-right circle displays the following information: 42, 68, 1,295, 2,489; and the bottom circle displays the following information: 68, 33, 2,489, 479. The intersection area is labeled 68. On the right, the Venn diagram is titled Differential expressed genes (down-regulated) and displays three circles: The circle on the top-left is labeled 2,4,6-tribromophenol, the circle on the top-right is labeled 2,4,6-triiodophenol, the circle at the bottom is labeled 2,4,6-trichlorophenol. The top-left circle displays the following information: 4,243, 100, 32, 72; the top-right circle displays the following information: 100, 72, 431, 326; and the bottom circle displays the following information: 32, 72, 326, 117. The intersection area is labeled 72. Figure 3B is a set of six scatter dot plots. On the top, the two scatter dot plots are titled 2,4,6-Trichlorophenol underscore up differentially expressed genes enrichment analysis and 2,4,6-trichlorophenol underscore down differentially expressed genes enrichment analysis, plotting lymphocyte homeostasis, negative regulation of intrinsic apoptotic signaling pathway, negative regulation of single stranded viral ribonucleic acid replication, negative regulation of T cell proliferation, positive regulation of macromolecule metabolic process; and DNA-templated transcription, initiation, natural killer cell lectin-like receptor binding, positive regulation of type 1 interferon production, regulation of innate immune response, T cell costimulation (y-axis) across gene ratio, ranging from 0.4 to 0.6 in increments of 0.1 and 0.15 to 0.25 in increments of 0.05 (x-axis), respectively. The negative log to the base 10 of (false discovery rate) ranges from 2.500 to 2.575 in increments of 0.025 and 2 to 8 in increments of 2. The gene number dot size ranges from 10 to 5 in unit decrements and 11 to 3 in decrements of 2. At the center, the two scatter dot plots are titled 2,4,6-Tribromophenol underscore up differentially expressed genes enrichment analysis and 2,4,6-Tribromophenol underscore down differentially expressed genes enrichment analysis, plotting cytoplasmic translational elongation, gene expression, negative regulation of cell population proliferation, negative regulation of cytokine-mediated signaling pathway, negative regulation of microglial cell activation; and cellular response to DNA damage stimulus, messenger ribonucleic acid processing, N6-methyladenosine-containing ribonucleic acid binding, negative regulation of apoptotic process, regulation of DNA replication (y-axis) across gene ratio, ranging from 0.25 to 1.00 in increments of 0.25 and 0.4 to 0.8 in increments of 0.1 (x-axis), respectively. The negative log to the base 10 of (false discovery rate) ranges from 2.2 to 2.6 in increments of 0.2 and 20 to 60 in increments of 20. The gene number dot size ranges from 16 to 4 in decrements of 4 and 200 to 50 in decrements of 50. In the bottom row, the two scatter dot plots are titled 2,4,6-Triiodophenol underscore up differentially expressed genes enrichment analysis and 2,4,6-triiodophenol underscore down differentially expressed genes enrichment analysis, plotting inhibitory MHC class 1 receptor activity, Lymphocyte apoptotic process, negative regulation of cytokine-mediated signaling pathway, negative regulation of nuclear factor kappa β transcription factor activity, pyroptosis; and killing of cells of other organism, positive regulation of cell growth, positive regulation of inflammatory response to antigenic stimulus, positive regulation of viral genome replication, viral entry into host cell (y-axis) across gene ratio, ranging from 0.3 to 0.8 in increments of 0.1 and 0.2 to 0.5 in increments of 0.1 (x-axis), respectively. The negative log to the base 10 of (false discovery rate) ranges from 2.4 to 3.2 in increments of 0.4 and 1.5 to 2.5 in increments of 0.5. The gene number dot size ranges from 20 to 4 in decrements of 4 and 8 to 2 in decrements of 2.

Significantly altered genes and pathways of mouse macrophages after exposure to 100μM 2,4,6-trihalophenols. (A) Venn diagram representing up- and down-regulated DEGs in RAW264.7 cells after exposure to TCP, TBP, or TIP. DEGs were defined as |log2Fold difference |1 and FDR <0.05. (B) SAPs in the TCP-, TBP-, and TIP-exposure groups. The up-regulated or down-regulated DEGs after TCP, TBP, or TIP exposure were used for GO enrichment analysis. The SAPs inside the gray box have at least two DEGs and FDR <0.05. The dot color and size are proportional to the FDR value and DEG number, respectively. The corresponding data are presented in Excel Table S6. RNA-seq was performed with two biological replicates (n=2). Note: DEGs, differentially expressed genes; FDR, false discovery rate; GO, Gene Ontology; MHC, major histocompatibility complex; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; SAPs, significantly altered pathways; TBP, 2,4,6-tribromophenol; TCP, 2,4,6-trichlorophenol; TIP, 2,4,6-triiodophenol.

To further interpret the transcriptome data, DEGs in the 2,4,6-trihalophenol–treated groups were selected for Gene Ontology (GO) enrichment analysis. The GO enrichment results indicated that genes among immune-related pathways differed after exposure to 2,4,6-trihalophenols compared with control (Figure 3B). However, the pathways associated with differentially expressed genes [significantly altered pathways (SAPs), DEGs 2, and FDR <0.05] were quite different in different exposure groups. TCP exposure was associated with differences in genes from pathways associated with the interaction between macrophages and other lymphocytes, especially T cells and natural killer cells. Specifically, TCP exposure was associated with the differential expression of genes involved in lymphocyte homeostasis, T cell proliferation, T cell costimulation, natural killer cell lectin-like receptor binding, innate immune response, and type I interferon production pathways. For the TBP group, genes associated with microglial cell activation and cytokine-mediated signaling pathways were differentially expressed. For the TIP group, genes from pathways related to antigen presentation and signal transduction were differentially expressed, including the inhibitory major histocompatibility complex (MHC) class I receptor activity pathway, the negative regulation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) transcription factor activity pathway, the negative regulation of cytokine-mediated signaling pathway, and the lymphocyte apoptotic process pathway. Meanwhile, genes associated with pathways regulating the killing of cells of other organisms, viral entry into host cell, and viral genome replication were all differentially expressed.

Expression of m6A Regulators in Macrophages

We first determined the transcriptional expression of m6A methyltransferases (METTL3, METTL14, and WTAP) using qRT-PCR. Compared with the control group, the mRNA levels of Mettl3 were >4.9-fold higher in the 200μM TBP- and TIP-exposure groups (p<0.01 for TBP, p<0.001 for TIP; Figure 4A). Consistent with this, compared with the control group, transcriptional expression of Mettl14 was significantly higher after exposure to 200μM TCP, TBP, or TIP by 2-fold (p<0.01 for TCP, p<0.05 for TBP, p<0.01 for TIP; Figure 4B). For Wtap, the 200μM TIP-exposure group exhibited a statistically significantly greater mRNA abundance (p<0.01; Figure 4C). Then, we evaluated the transcriptional expression of the m6A demethylases (FTO and ALKBH5). Exposure to 200μM TCP, TBP, or TIP was associated with greater transcriptional expression of Fto (p<0.001 for TCP, p<0.01 for TBP, p<0.05 for TIP; Figure 4D). The mRNA levels of Alkbh5 were greater after the administration of 200μM TBP or TIP (p<0.05 for TBP, p<0.001 for TIP; Figure 4E). There were no statistically significant differences in the mRNA levels of the m6A binding proteins in all exposure groups except Ythdf2 (p<0.05 for the 200μM TCP group, p<0.05 for the 200μM TBP group, p<0.001 for the 200μM TIP group; Figure 4F–J).

Figure 4.

Figures 4A to 4J are bar graphs titled METTL3, METTL14, WTAP, FTO, ALKBH5, YTHDF1, YTHDF2, YTHDF3, YTHDC1, and YTHDC2, plotting fold difference (versus 0 micromolar), ranging from 0 to 8 in increments of 2 (y-axis) across 2,4,6-trichlorophenol, 2,4,6-tribromophenol, 2,4,6-triiodophenol (x-axis) for 50 micromolar, 100 micromolar, and 200 micromolar. Figure 4K is a set of three Western blots. In the top row, the Western blot displays four main columns, namely 0 micromolar, 50 micromolar, 100 micromolar, and 200 micromolar. The 50 micromolar, 100 micromolar, and 200 micromolar columns are each subdivided into three columns, namely, 2,4,6-trichlorophenol, 2,4,6-tribromophenol, 2,4,6-triiodophenol, and two rows, namely, METTL3 and glyceraldehyde-3-phosphate dehydrogenase. In the center row, the Western blot displays four main columns, namely 0 micromolar, 50 micromolar, 100 micromolar, and 200 micromolar. The 50 micromolar, 100 micromolar, and 200 micromolar columns are each subdivided into three columns, namely, 2,4,6-trichlorophenol, 2,4,6-tribromophenol, 2,4,6-triiodophenol, and two rows, namely, METTL14 and glyceraldehyde-3-phosphate dehydrogenase. In the bottom row, the Western blot displays four main columns, namely 0 micromolar, 50 micromolar, 100 micromolar, and 200 micromolar. The 50 micromolar, 100 micromolar, and 200 micromolar columns are each subdivided into three columns, namely, 2,4,6-trichlorophenol, 2,4,6-tribromophenol, 2,4,6-triiodophenol, and two rows, namely, WTAP and glyceraldehyde-3-phosphate dehydrogenase. Figure 4L is a set of three bar graphs, plotting relative protein abundance of METTL3 per glyceraldehyde-3-phosphate dehydrogenase, ranging from 0.0 to 2.5 in increments of 0.5; relative protein abundance of METTL14 per glyceraldehyde-3-phosphate dehydrogenase, ranging from 0 to 8 in increments of 2; and relative protein abundance of WTAP per glyceraldehyde-3-phosphate dehydrogenase, ranging from 0 to 4 in unit increments (y-axis) across 2,4,6-trichlorophenol, 2,4,6-tribromophenol, 2,4,6-triiodophenol (x-axis) across 0 micromolar, 50 micromolar, 100 micromolar, and 200 micromolar.

The effects of TCP, TBP, and TIP on the expression of m6A methyltransferases, demethylases, and m6A binding proteins in RAW264.7 cells. (A–J) Transcriptional expression of m6A methyltransferases, demethylases, and m6A binding proteins in RAW264.7 cells. After exposure to different concentrations (0, 50, 100, 200μM) of TCP, TBP, or TIP for 24 h, the mRNA levels of Mettl3, Mettl14, Wtap, Fto, Alkbh5, Ythdf1, Ythdf2, Ythdf3, Ythdc1, and Ythdc2 were quantitatively measured via qRT-PCR. Results are shown as fold differences compared with the control group (0μM). 1=no difference. Data are expressed as mean±SD (n=3 biological replicates, each with two technical replicates). Data were analyzed by one-way ANOVA with the Tukey post hoc test. *p<0.05, **p<0.01, ***p<0.001. The corresponding data are presented in Excel Table S7. (K,L) Protein abundance of METTL3, METTL14, and WTAP in RAW264.7 cells. After exposure to different concentrations (0, 50, 100, 200μM) of TCP, TBP, or TIP for 24 h, protein abundance of METTL3, METTL14, WTAP, and the loading control (GAPDH) was analyzed using Western blotting. Western blotting was repeated with independent sample preparations three times (n=3 biological replicates; Figure S5). (K) One representative figure for each m6A methyltransferase was shown. (L) Western blotting results were quantified with Image Lab. 1=no difference. Data are expressed as mean±SD (n=3 biological replicates). Data were analyzed by one-way ANOVA with the Tukey post hoc test. *p<0.05, **p<0.01, ***p<0.001. The corresponding data are summarized in Excel Table S8. Note: ANOVA, analysis of variance; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; m6A, N6-methyladenosine; qRT-PCR, quantitative reverse transcriptase polymerase chain reaction; SD, standard deviation; TBP, 2,4,6-tribromophenol; TCP, 2,4,6-trichlorophenol; TIP, 2,4,6-triiodophenol.

The mRNA levels of m6A methyltransferases were significantly higher in exposed cells, especially Mettl3. Therefore, it was necessary to evaluate the protein abundance of m6A methyltransferases in macrophages. When the exposure concentration increased to 100 or 200μM, the protein abundance of METTL3 was significantly greater in three exposure groups compared with the control group (Figure 4K,L; Figure S5). For METTL14, cells exposed to each of 2,4,6-trihalophenols did not exhibit any statistically significant differences in protein expression. For WTAP, the protein abundance was significantly higher after the administration of 200μM TCP, 200μM TBP, and 100 and 200μM TIP.

Because there was no significant difference in the transcriptional levels of m6A methyltransferases in RAW264.7 cells after exposure to 100μM 2,4,6-trihalophenols, the transcriptional expression of m6A methyltransferases was further evaluated in mouse peritoneal macrophages after exposure to 100μM TCP, TBP, and TIP (Figure S6). Compared with the control group, mouse peritoneal macrophages exposed to TCP or TBP exhibited significantly greater transcriptional expression of Wtap (p<0.01 for the TCP- and TBP-exposure groups); however, the mRNA levels of Mettl3 in the TCP- and TBP-exposure groups were lower p<0.05 (for the TCP- and TBP-exposure groups). Meanwhile, RNA-seq results of RAW264.7 cells showed that there was greater Mettl14 expression in the TIP group and lower Mettl14 expression in the TBP group after exposure to 100μM 2,4,6-trihalophenols (Table S5).

RNA m6A Modification Status in Macrophages

To determine whether the m6A levels differed in the TCP-, TBP-, and TIP-exposure groups, we measured the global m6A levels of total RNA from 2,4,6-trihalophenol–treated RAW264.7 cells using an m6A dot blot. Methylene blue staining was used as a loading control after visualizing in white light. After exposure to 50, 100, or 200μM 2,4,6-trihalophenols, we detected differences in m6A levels in the 2,4,6-trihalophenol exposure groups. TIP-exposed cells exhibited greater modification levels (Figure 5; Figure S7).

Figure 5.

Figure 5A is a set of two dot blots. In the top row, the blot plots Total ribonucleic acid (nanograms), ranging from 200 to 400 in increments of 200 and 400 to 800 in increments of 400 (y-axis) across N6-methyladenosine (x-axis) for control, 2,4,6-trichlorophenol with 50 micromolar, 2,4,6-tribromophenol with 50 micromolar, 2,4,6-triiodophenol with 50 micromolar. In the bottom row, the blot plots Total ribonucleic acid (nanograms), ranging from 200 to 400 in increments of 200 and 400 to 800 in increments of 400 (y-axis) across methylene blue (x-axis) for control, 2,4,6-trichlorophenol with 50 micromolar, 2,4,6-tribromophenol with 50 micromolar, 2,4,6-triiodophenol with 50 micromolar. Figure 5B is a set of two dot blots. In the top row, the blot plots Total ribonucleic acid (nanograms), ranging from 200 to 400 in increments of 200 and 400 to 800 in increments of 400 (y-axis) across N6-methyladenosine (x-axis) for control, 2,4,6-trichlorophenol with 100 micromolar, 2,4,6-tribromophenol with 100 micromolar, 2,4,6-triiodophenol with 100 micromolar. In the bottom row, the blot plots Total ribonucleic acid (nanograms), ranging from 200 to 400 in increments of 200 and 400 to 800 in increments of 400 (y-axis) across methylene blue (x-axis) for control, 2,4,6-trichlorophenol with 100 micromolar, 2,4,6-tribromophenol with 100 micromolar, 2,4,6-triiodophenol with 100 micromolar. Figure 5C is a set of two dot blots. In the top row, the blot plots Total ribonucleic acid (nanograms), ranging from 200 to 400 in increments of 200 and 400 to 800 in increments of 400 (y-axis) across N6-methyladenosine (x-axis) for control, 2,4,6-trichlorophenol with 200 micromolar, 2,4,6-tribromophenol with 200 micromolar, 2,4,6-triiodophenol with 200 micromolar. In the bottom row, the blot plots Total ribonucleic acid (nanograms), ranging from 200 to 400 in increments of 200 and 400 to 800 in increments of 400 (y-axis) across methylene blue (x-axis) for control, 2,4,6-trichlorophenol with 200 micromolar, 2,4,6-tribromophenol with 200 micromolar, 2,4,6-triiodophenol with 200 micromolar.

The m6A levels in RAW264.7 cells after exposure to TCP, TBP, or TIP at concentrations of (A) 50μM, (B) 100μM, or (C) 200μM. The m6A levels of total RNA were measured by dot blot (upper panel). Methylene blue staining was used as a loading control (lower panel). Dot blot analysis was repeated with independent sample preparations three times (n=3 biological replicates; Figure S7). Note: m6A, N6-methyladenosine; TBP, 2,4,6-tribromophenol; TCP, 2,4,6-trichlorophenol; TIP, 2,4,6-triiodophenol.

Macrophage Transcriptome-Wide m6A Profile (m6A-Seq)

We used m6A-seq to profile m6A levels across the transcriptome of RAW264.7 cells with or without 2,4,6-trihalophenol exposure. In both the control and 2,4,6-trihalophenol–treated groups, the m6A peaks were mainly distributed in the 3′ untranslated (UTR) and exon regions, with only a small number of peaks harboring in the 5′UTR, intron, and intergenic regions (Figure 6A). The TIP group had a higher number of transcripts with multisite m6A modifications (m6A peak number per transcript 3) than other exposure groups and the control group (Figure S8). Meanwhile, the TIP group had the lowest number of transcripts with a single-site m6A modification (m6A peak number per transcript=1), and the control group had the highest.

Figure 6.

Figure 6A is a set of four pie charts. The first pie chart is titled Control and displays the following information: 5′ untranslated region is 9.66 percent, 3′ untranslated region is 56.64 percent, exon is 31.05 percent, intron is 2.44 percent, and intergenic is 0.21 percent. The second pie chart is titled 2,4,6-Trichlorophenol and displays the following information: 5′ untranslated region is 8.47 percent, 3′ untranslated region is 54.41 percent, exon is 34.19 percent, intron is 2.64 percent, and intergenic is 0.29 percent. The third pie chart is titled 2,4,6-Tribromophenol and displays the following information: 5′ untranslated region is 9.23 percent, 3′ untranslated region is 56.87 percent, exon is 32.13 percent, intron is 1.54 percent, and intergenic is 0.23 percent. The fourth pie chart is titled 2,4,6-Triiodophenol and displays the following information: 5′ untranslated region is 8.29 percent, 3′ untranslated region is 53.32 percent, exon is 35.26 percent, intron is 2.88 percent, and intergenic is 0.25 percent. Figure 6B is a Venn diagram titled N6-Methyladenosine genes overlap and displays four circles. From the left, 2,4,6-trichlorophenol, control, 2,4,6-tribromophenol, and 2,4,6-triiodophenol. 2,4,6-Trichlorophenol displays the following information: 195, 139, 21, 144, 48, 7,338, 370, 1,204. Control displays the following information: 536, 139, 238, 144, 134, 7,338, 1,204, 211. 2,4,6-Tribromophenol displays the following information: 86, 35, 238, 134, 144, 7,338, 21, 48. 2,4,6-Triiodophenol displays the following information: 35, 553, 134, 211, 7,338, 1,204, 48, 370. The intersection area is labeled 7,338. Figure 6C is a set of three Venn diagrams. On the left, the Venn diagram is titled Control versus 2,4,6-trichlorophenol and displays the following information: 1,119 under control, 634 under 2,4,6-trichlorophenol, and the intersection area is labeled 8,825. At the center, the Venn diagram is titled Control versus 2,4,6-tribromophenol and displays the following information: 2,090 under control, 190 under 2,4,6-tribromophenol, and the intersection area is labeled 7,854. On the right, the Venn diagram is titled Control versus 2,4,6-triiodophenol and displays the following information: 1,057 under control, 1,006 under 2,4,6-triiodophenol, and the intersection area is labeled 8,887. Figure 6D is a horizontal bar graph, plotting 2,4,6-triiodophenol, including immune system process, positive regulation of Nuclear factor kappa β-inducing kinase or Nuclear factor kappa β signaling, positive regulation of inflammatory response, defense response to gram-negative bacterium, programmed cell death, inhibitory MHC class 1 receptor activity, antibacterial humoral response, defense response to gram-positive bacterium; 2,4,6-tribromophenol, including leukocyte activation involved in inflammatory response, negative regulation of T-helper 17 type immune response, regulation of viral budding via host ESCRT complex, regulation of inflammatory response to wounding, neutrophil-mediated killing of bacterium, regulation of chemokine (C-X-C motif) ligand 1 production, induced systemic resistance, regulation of natural killer cell activation; 2,4,6-trichlorophenol, including negative regulation of Ras protein signal transduction, regulation of interferon-gamma-mediated signaling pathway, CD4-positive, alpha-beta T cell activation, negative regulation of immune response, regulatory T cell apoptotic process, positive regulation of chronic inflammatory response, negative regulation of immune system process, and negative regulation of tumor necrosis factor-mediated signaling pathway (y-axis) across negative log to the base 10 of (false discovery rate) enrichment of N6-methyladenosine genes, ranging from 0.0 to 1.5 in increments of 0.5 (x-axis) for 2,4,6-trichlorophenol, 2,4,6-tribromophenol, and 2,4,6-triiodophenol.

m6A-seq analysis of mouse macrophages after exposure to 100μM TCP, TBP, or TIP. (A) Distribution of m6A peaks across the transcriptome of RAW264.7 cells with or without 2,4,6-trihalophenol exposure. (B) Diagram representing the overlap of m6A-modified genes with or without TCP, TBP, or TIP exposure. (C) Venn diagrams representing m6A-modified genes in the 2,4,6-trihalophenol exposure groups and the control group. (D) GO pathways of RAW264.7 cells enriched among uniquely m6A-modified genes after 2,4,6-trihalophenol exposure. The uniquely m6A-modified genes after TCP, TBP, or TIP exposure were used for GO enrichment analysis. The red, blue, and green boxes indicate the TCP-, TBP-, and TIP-exposure groups, respectively. GO enrichment analysis showed a significant enrichment in immune-related, infection-associated and cancer-associated signaling pathways (FDR <0.05). The m6A-seq was performed with two biological replicates (n=2). Note: ESCRT, endosomal sorting complex required for transport; FDR, false discovery rate; GO, Gene Ontology; m6A, N6-methyladenosine; MHC, major histocompatibility complex; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; NiK, nuclear factor kappa β-inducing kinase; TBP, 2,4,6-tribromophenol; TCP, 2,4,6-trichlorophenol; TIP, 2,4,6-triiodophenol; UTR, untranslated region.

The m6A-seq data demonstrated significant differences in m6A levels in all exposure groups. In total, 7,338 genes were commonly modified in all groups (Figure 6B). Six hundred thirty-four, 190, and 1,006 genes were uniquely modified with m6A after TCP, TBP, and TIP exposure, respectively (Figure 6C). TIP exposure not only up-regulated the expression of most genes (Figure 3A), but it also exhibited the biggest influence on the m6A levels of macrophages compared with TCP and TBP.

Furthermore, GO enrichment analysis of uniquely m6A-modified genes after TCP, TBP, or TIP exposure were performed. Significantly enriched pathways were closely associated with inflammation and pathogen resistance (Figure 6D). TCP-exposed cells had different m6A peaks in genes related to immune-related pathways, including cellular immunity and inflammatory response. Specifically, cells exposed to TCP had higher levels of m6A in genes related to the T cell activation pathway, the regulatory T cell apoptotic process pathway, the chronic inflammatory response pathway, and the cytokine-mediated signaling pathways (tumor necrosis factor- and interferon-gamma–mediated signaling pathways). Cells exposed to TBP exhibited greater m6A levels in genes related to several immune-related pathways, especially pathogen defense pathways, such as the induced systemic resistance pathway, the leukocyte activation pathway, the neutrophil-mediated killing of bacterium pathway, and the regulation of the viral budding pathway. Similar to the TBP group, the m6A-modified genes unique to the TIP group were associated with several pathways related to immune response and pathogen resistance. Notably, cells exposed to TIP had higher levels of m6A in genes related to the antibacterial humoral response pathway, as well as a defense response to gram-positive and gram-negative bacterium pathways.

Joint analysis of RNA-seq and m6A-seq data was used for enriching DEGs with significantly altered m6A modifications after TCP, TBP, or TIP exposure. After 2,4,6-trihalophenol exposure, genes associated with several notably different Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways had significantly different levels of m6A modifications (Figure 7A). Therein, the m6A levels of genes associated with pattern recognition receptors [retinoic acid-inducible gene-I (RIG-I)-like receptors and nucleotide-binding and oligomerization domain (NOD)-like receptors], the inflammatory mediator regulation of transient receptor potential (TRP) channels pathway, and the NF-κB signaling pathway were significantly different after exposure compared with control. Consistent with these immune-related pathways, several m6A-altered KEGG pathways were associated with pathogen infection (Figure 7A). These pathways were related to virus, bacterium, and parasite infection, including the herpes simplex virus 1 infection pathway, the Salmonella infection pathway, and the African trypanosomiasis pathway. In addition, in the TIP group, genes associated with the endometrial cancer and thyroid cancer pathways were remarkably different and had significantly different m6A peaks.

Figure 7.

Figure 7A is a horizontal bar graph, plotting 2,4,6-Triiodophenol, including thyroid cancer, endometrial cancer, NOD-like receptor signaling pathway, nuclear factor kappa β signaling pathway, apoptosis, herpes simplex virus 1 infection; 2,4,6-tribromophenol, including hedgehog signaling pathway, C-type lectin receptor signaling pathway, autophagy–animal, R I G-1-like receptor signaling pathway, Wnt signaling pathway, selenocompound metabolism; 2,4,6-trichlorophenol, including mTOR signaling pathway, inflammatory mediator regulation of TRP channels, Wnt signaling pathway, herpes simplex virus 1 infection, Salmonella infection, African trypanosomiasis (y-axis) across negative log to the base 10 of (false discovery rate) Kyoto Encyclopedia of Genes and Genomes pathways enrichment, ranging from 0.0 to 1.5 in increments of 0.5 (x-axis) for 2,4,6-trichlorophenol, 2,4,6-tribromophenol, and 2,4,6-triiodophenol. Figure 7B is a set of three bar graphs. On the left, two bar graphs titled Tumor necrosis factor lowercase alpha N6-methyladenosine immunoprecipitation quantitative polymerase chain reaction, plotting fold change (versus control), ranging from 0.0 to 2.0 in increments of 0.5 (y-axis) across 5′ untranslated region and 3′ untranslated region (x-axis) for control, 2,4,6-trichlorophenol, 2,4,6-tribromophenol, and 2,4,6-triiodophenol. On the right, a bar graph titled Eukaryotic translation initiation factor 2 alpha kinase 2 N6-methyladenosine immunoprecipitation quantitative polymerase chain reaction, plotting fold change (versus control), ranging from 0.0 to 1.5 in increments of 0.5 (y-axis) across 3′ untranslated region (x-axis) for control, 2,4,6-trichlorophenol, 2,4,6-tribromophenol, and 2,4,6-triiodophenol.

The association of m6A with altered pathways and immune-related genes in RAW264.7 cells after 2,4,6-trihalophenol exposure. (A) KEGG pathways enriched among DEGs together with significantly altered m6A in RAW264.7 cells after 100μM TCP, TBP, or TIP exposure. The red, blue, and green boxes represent the TCP-, TBP-, and TIP-exposure groups, respectively. The SAPs have at least three DEGs and FDR <0.05. The corresponding data are presented in Excel Table S9. (B) The effects of 2,4,6-trihalophenol pretreatment on m6A levels of Tnf-α and Eif2ak2 in RAW264.7 cells challenged with T. gondii. RAW264.7 cells were pretreated with 100μM TCP, TBP, or TIP for 24 h. Then, the cells were rinsed, replenished with normal culture medium, and infected with T. gondii for another 24 h. The m6A levels were analyzed using m6A-IP-qPCR. 1=no difference. Data are expressed as mean±SD (n=2 biological replicates). Unpaired Student’s t-test was conducted for two-group comparison. *p<0.05, **p<0.01. The corresponding data are summarized in Excel Table S10. Note: DEGs, differentially expressed genes; Eif2ak2, eukaryotic translation initiation factor 2-alpha kinase 2; FDR, false discovery rate; IP, immunoprecipitation; KEGG, Kyoto Encyclopedia of Genes and Genomes; m6A, N6-methyladenosine; mTOR, mammalian target of rapamycin; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; NOD, nucleotide-binding and oligomerization domain; qPCR, quantitative polymerase chain reaction; RIG, retinoic acid-inducible gene; SAPs, significantly altered pathways; SD, standard deviation; TBP, 2,4,6-tribromophenol; TCP, 2,4,6-trichlorophenol; TIP, 2,4,6-triiodophenol; TNF, tumor necrosis factor; TRP, transient receptor potential; UTR, untranslated region.

Furthermore, we analyzed the m6A modifications of immune-related genes using m6A-IP-qPCR on RAW264.7 cells that were challenged with parasite T. gondii infection. RAW264.7 cells were pretreated with 100μM TCP, TBP, or TIP for 24 h. Then, the treated cells were rinsed, replenished with normal culture medium, and infected with T. gondii for another 24 h. The m6A-seq results showed that m6A peaks in the 5′UTR or 3′UTR of the inflammatory cytokine Tnf-α were up-regulated after 24 h-exposure to TBP or TIP (Table S6). After T. gondii infection, m6A peaks in the 3UTR of Tnf-α remained up-regulated in both the TBP and TIP groups when compared with the control group (p<0.01 for TBP, p<0.05 for TIP). In addition, m6A peaks in the 5′UTR of Tnf-α were also up-regulated in both the TBP and TIP groups (p<0.05; Figure 7B). The m6A-seq results showed that m6A peaks in the 3′UTR of protein kinase R Eif2ak2 were up-regulated after TCP or TIP exposure (Table S6). After T. gondii infection, m6A peaks in the 3′UTR of Eif2ak2 were still up-regulated in the TCP and TIP groups (p<0.05; Figure 7B).

Effects of 2,4,6-Trihalophenols on Human PBMCs

Finally, the effects of TCP, TBP, and TIP on m6A modifications of human immune cells were evaluated. Human PBMCs were exposed to 100μM TCP, TBP, and TIP. The transcriptional expression of m6A methyltransferases, demethylases, and m6A binding proteins were measured. Compared with the control group, the mRNA levels of WTAP were significantly higher in the TBP group (p<0.05), whereas the mRNA levels of METTL3 were higher in the TCP group (p<0.05; Figure 8A–C). Meanwhile, exposure to TBP was associated with significantly greater transcriptional expression of demethylase FTO (p<0.001) and m6A binding protein YTHDF2 (p<0.001), YTHDF3 (p<0.001), and YTHDC1 (p<0.01; Figure 8D–J).

Figure 8.

Figures 8A to 8J are bar graphs titled METTL3, METTL14, WTAP, FTO, ALKBH5, YTHDF1, YTHDF2, YTHDF3, YTHDC1, and YTHDC2, plotting fold difference (versus 0 micromolar), ranging from 0 to 4 in unit increments (y-axis) across 2,4,6-trichlorophenol, 2,4,6-tribromophenol, and 2,4,6-triiodophenol (x-axis) for 2,4,6-trichlorophenol, 2,4,6-tribromophenol, and 2,4,6-triiodophenol, respectively. Figure 8K is a set of two dot blots. In the top row, the blot plots Total ribonucleic acid (nanograms), ranging from 125 to 250 in increments of 125 and 250 to 500 in increments of 250 (y-axis) across N6-methyladenosine (x-axis) for control, 2,4,6-trichlorophenol, 2,4,6-tribromophenol, 2,4,6-triiodophenol. In the bottom row, the blot plots Total ribonucleic acid (nanograms), ranging from 125 to 250 in increments of 125 and 250 to 500 in increments of 250 (y-axis) across methylene blue (x-axis) for control, 2,4,6-trichlorophenol, 2,4,6-tribromophenol, 2,4,6-triiodophenol.

The effects of TCP, TBP, and TIP on the expression of m6A regulators and global m6A levels in human PBMCs. (A–J) Transcriptional expression of m6A methyltransferases, demethylases, and m6A binding proteins in human PBMCs after 2,4,6-trihalophenol exposure. After exposure to 100μM TCP, TBP, and TIP for 24 h, mRNA levels of METTL3, METTL14, WTAP, FTO, ALKBH5, YTHDF1, YTHDF2, YTHDF3, YTHDC1, and YTHDC2 were quantitatively measured via qRT-PCR. Results are shown as fold differences compared with the control group (0μM). 1=no difference. Data are expressed as mean±SD (n=3 biological replicates). Data were analyzed by one-way ANOVA with the Tukey post hoc test. *p<0.05, **p<0.01, ***p<0.001. The corresponding data are summarized in Excel Table S11. (K) Global m6A levels in human PBMCs after exposure to 100μM 2,4,6-trihalophenols. The m6A levels of total RNA were measured by dot blot analysis (upper panel). Methylene blue staining was used as a loading control (lower panel). Note: ANOVA, analysis of variance; m6A, N6-methyladenosine; PBMCs, peripheral blood mononuclear cells; qRT-PCR, quantitative reverse transcriptase polymerase chain reaction; SD, standard deviation; TBP, 2,4,6-tribromophenol; TCP, 2,4,6-trichlorophenol; TIP, 2,4,6-triiodophenol.

Furthermore, we detected the global m6A levels of total RNA from 2,4,6-trihalophenol–treated human PBMCs. After 100μM 2,4,6-trihalophenol exposure, the m6A levels were all greater in the TCP-, TBP-, and TIP-exposure groups compared with the control group (Figure 8K).

Discussion

In this study, the results of the CCK8 assay demonstrated that TCP, TBP, and TIP could impair the cell viability of mouse macrophage RAW264.7 cells at high concentrations. Ly6C is an important pro-inflammatory marker of macrophages. The recruitment of Ly6C+ macrophages was closely related to a variety of host inflammatory and anti-infectious responses in mice.45,46 The lower expression of Ly6C in cells exposed to 2,4,6-trihalophenols suggested that trihalophenolic DBPs might affect macrophage-mediated resistance to infection (Figure 1). Considering the differences among pathogens, we used both bacteria and intracellular parasites to investigate the effects of 2,4,6-trihalophenols on phagocytosis and the pathogen clearance ability of macrophages. Cells exposed to TBP or TIP demonstrated greater numbers of E. coli after infection, suggesting that exposure might affect the cells’ response to or elimination of bacterial infection (Figure 2B). Interestingly, bacteria were identified intracellularly, but they were apparently not killed by the cells exposed to TIP, suggesting that TIP may have inhibited the bactericidal ability of macrophages but not the ability to phagocytize them (Figure 2A). T. gondii is a protozoan parasite capable of infecting humans and many warm-blooded animals.47 T. gondii infection displays obvious opportunistic pathogenic characteristics in human immunodeficiency virus (HIV)-positive people,48 solid-organ transplant recipients,49 and pregnant women.50,51 Under normal conditions, macrophages inhibit the overproliferation of T. gondii.52,53 However, in immunocompromised hosts, T. gondii proliferates rapidly in macrophages.54 Therefore, we used the parasite burden of T. gondii to evaluate macrophage-mediated resistance to parasite infection. In this study, mouse macrophages exposed to TBP or TIP appeared less able to kill T. gondii, and TIP had a stronger effect than its brominated analog (Figure 2C,D). RNA-seq results showed differences in genes associated with antigen presentation and signal transduction in TIP-exposed cells (Figure 3) that was commensurate with the impaired ability of RAW264.7 cells to control parasite infection after exposure to TIP. In sum, the present study demonstrated that exposure to 2,4,6-trihalophenols, especially TIP, induced remarkable immune suppression of mouse macrophages.

According to previous reports, the concentrations of 2,4,6-trihalophenols in drinking water samples in China reached 0.46215 ng/L,2,3 and the total organic halogen (TOX) in drinking water samples of 23 cities in the United States and Canada were 22273μg/L.55 Although the environmental concentrations of 2,4,6-trihalophenols are much lower than the concentrations used in this study, it was reported that 2,4,6-trihalophenols could remain in the body for a relatively long time.11,12,56,57 In addition, in special occupational settings, the ubiquity of exposure to 2,4,6-trihalophenols leads to abundant enrichment of such pollutants in particular individuals. For example, TCP was detected in the urine of sawmill workers (where chlorophenols were used to prevent fungal growth in lumber after sawing) at concentrations ranging from 1 to 11.8μM,56 which were up to 4,000 times higher than the average concentration of TCP detected in human urine (0.59μg/L) in the German Environmental Survey.11 Therefore, our results can inform the immunotoxicity risk of long-term exposure or occupational exposure to 2,4,6-trihalophenols.

It was reported that the toxicity of an electrophilic DBP to a nucleophile site and that of a nucleophilic DBP to an electrophile site might increase with decreasing energy of the lowest unoccupied molecular orbital (ELUMO; related to molecular reactions with nucleophiles) and increasing energy of the highest occupied molecular orbital (EHOMO; related to molecular reactions with electrophiles).8 There was an obvious decrease of the three 2,4,6-trihalophenols in ELUMO and an increasing trend in EHOMO from TCP to TIP.17,8 Thus, the toxicity of 2,4,6-trihalophenols commonly followed the rank order of iodinated DBP>brominated analog>chlorinated analog.17,58,59

Different from DNA and protein modifications, epitranscriptomic methylation modulates gene expressions and functionalities more rapidly and flexibly following exposure to environmental toxicants.38,39,60 There are >100 kinds of chemical modifications located on RNA, among which m6A was the most prevalent internal modification.61 Studies in recent years have shown that exposure to environmental stressors could induce global m6A modification changes. Specifically, exposure to carcinogens [particulate matter (PM) and sodium arsenite] and endocrine disruptors [bisphenol A (BPA) and vinclozolin], had obvious effects on the global m6A modifications.38 Participants exposed to high PM 2.5μm in aerodynamic diameter (PM2.5) exhibited higher expression of m6A methyltransferases (METTL3 and WTAP), demethylases (FTO and ALKBH5), and binding protein Heterogeneous Nuclear Ribonucleoprotein C (HNRPC) compared with those in the low-exposure control group.38 Compared with nonsmokers, the total m6A levels in the peripheral blood of smokers were lower by 10.7%.39 In addition, m6A modification was also involved in the intergenerational toxic mechanism of benzo[a]pyrene (BaP), a widespread pollutant in aquatic environments.60

In this study, exposure to 2,4,6-trihalophenols was associated with differences in m6A levels in mouse macrophages, accompanied by differences in the abundance of methyltransferases (Figures 4 and 5). Therein, cells exposed to TIP exhibited the most obvious differences in global m6A levels and expression of m6A methyltransferases. Based on these results, we speculated that after 2,4,6-trihalophenol exposure, the observed immune suppression of macrophages might be associated with remarkable differences in RNA m6A modifications.

In addition, we also detected the effects of 2,4,6-trihalophenols on m6A modifications of human PBMCs (Figure 8). Global m6A levels of human PBMCs were greater in all three 2,4,6-trihalophenol exposure groups than in the control group. The results suggested that 2,4,6-trihalophenol–induced m6A disturbance was not unique to mouse macrophages. Differences in m6A regulators differed between RAW264.7 cells and human PBMCs. In RAW264.7 cells, the transcriptional expressions of m6A regulators did not exhibit any significant differences after exposure to 100μM TCP, TBP, or TIP. However, the mRNA levels of partial m6A regulators in PBMCs were significantly different after the same treatment. This is, perhaps, because PBMCs are a mixture of immune cell types. The immune cells interact to regulate the functions of each other. In addition, primary cells might be more susceptible than immortalized cell lines.6264

Although recent environmental toxicology studies have gradually paid attention to RNA m6A modification, the specific genes or pathways modulated by m6A following environmental pollutant exposure remain unclear. There is still a lack of in-depth research on pollutant-induced variations of m6A modification. In this study, the dot blot results exhibited the global differences in m6A modifications in response to 2,4,6-trihalophenol exposure; however, it was a nonquantitative result. A more advanced and precise study was required for the m6A profile. Thus, we performed the high-throughput m6A-seq. Transcriptome-wide m6A-seq revealed the distribution patterns of m6A across mouse macrophage transcriptome after exposure to 2,4,6-trihalophenols (Figure 6). Exposure to 2,4,6-trihalophenols affected the m6A levels of several genes associated with immune-related pathways. Joint analysis of m6A-seq and RNA-seq data confirmed the potential association of abnormal m6A levels with altered immune-related pathways (Figure 7A), suggesting m6A as a potential biomarker for the immunotoxicity of environmental pollutants. To the best of our knowledge, this was the first time that m6A-seq has been used to map the m6A modification in macrophages in the area of environmental health.

The immune system is critical to the survival of individuals when dealing with internal and external pathogens. Thus, 2,4,6-trihalophenol-induced m6A variation and immune dysfunction of macrophages deserve special attention. However, how is m6A related to the immune dysfunction in DBP-pretreated cells that are also challenged with infection? To probe this process, we performed the m6A-IP-qPCR on RAW264.7 cells that were also challenged with parasite T. gondii. TNF-α is an inflammatory cytokine produced by macrophages and plays a vital role in cell resistance against T. gondii.65 EIF2AK2 is known as protein kinase R and selectively regulates the gene expression in the immune response.66 After T. gondii infection, the m6A levels of Tnf-α and Eif2ak2 remained significantly up-regulated in the 2,4,6-trihalophenol–pretreated groups compared with the control group (Figure 7B). The m6A-modified RNAs can be degraded by m6A binding proteins,67 and then the expressions of corresponding genes are down-regulated. These findings were commensurate with the dampened ability of macrophages to control infection after 2,4,6-trihalophenol exposure. In the future, further studies are needed to get a full and in-depth understanding of the underlying mechanism.

Supplementary Material

Acknowledgments

M.Q., L.H., M.L., T.S., X.J., C.S., and C.Z. contributed to the methodology and data collection. M.Q., M.L., J.Z., and X.J. completed the analyses and interpretation of data. J.Q., X.L., Q.Z., and Y.W. conceptualized the project. J.Q., Q.Z., and X.L. contributed to funding acquisition. J.Q., X.L., Y.W., Y.P., and Q.Z. supervised the project. M.Q. and J.Q. drafted the original manuscript. J.Q., Q.Z., X.L., and Y.W. drafted the final manuscript with critical review and revision.

We thank Wei Shi (Nanjing University) for helpful discussion.

This work was supported by the Natural Science Foundation of Jiangsu Province, China [BK20200088 (to J.Q.), BK20211509 (to Q.Z.)], the National Natural Science Foundation of China [22376099 (to Q.Z.), 52070093 (to Q.Z.), and 32070868 (to X.L.)], and the State Key Laboratory of Pollution Control and Resource Reuse Open Foundation [PCRRF22004 (to J.Q.)], as well as a grant from the Key Laboratory of Pathogen Biology of Jiangsu Province [KLPBJP-K202008 (to X.L.)].

References

  • 1.Pan Y, Zhang X. 2013. Four groups of new aromatic halogenated disinfection byproducts: effect of bromide concentration on their formation and speciation in chlorinated drinking water. Environ Sci Technol 47(3):1265–1273, PMID: , 10.1021/es303729n. [DOI] [PubMed] [Google Scholar]
  • 2.Pan Y, Li W, An H, Cui H, Wang Y. 2016. Formation and occurrence of new polar iodinated disinfection byproducts in drinking water. Chemosphere 144:2312–2320, PMID: , 10.1016/j.chemosphere.2015.11.012. [DOI] [PubMed] [Google Scholar]
  • 3.Pan Y, Wang Y, Li A, Xu B, Xian Q, Shuang C, et al. 2017. Detection, formation and occurrence of 13 new polar phenolic chlorinated and brominated disinfection byproducts in drinking water. Water Res 112:129–136, PMID: , 10.1016/j.watres.2017.01.037. [DOI] [PubMed] [Google Scholar]
  • 4.Zhai H, Zhang X. 2011. Formation and decomposition of new and unknown polar brominated disinfection byproducts during chlorination. Environ Sci Technol 45(6):2194–2201, PMID: , 10.1021/es1034427. [DOI] [PubMed] [Google Scholar]
  • 5.Yang M, Zhang X, Liang Q, Yang B. 2019. Application of (LC/)MS/MS precursor ion scan for evaluating the occurrence, formation and control of polar halogenated DBPs in disinfected waters: a review. Water Res 158:322–337, PMID: , 10.1016/j.watres.2019.04.033. [DOI] [PubMed] [Google Scholar]
  • 6.Jiang J, Zhang X, Zhu X, Li Y. 2017. Removal of intermediate aromatic halogenated DBPs by activated carbon adsorption: a new approach to controlling halogenated DBPs in chlorinated drinking water. Environ Sci Technol 51(6):3435–3444, PMID: , 10.1021/acs.est.6b06161. [DOI] [PubMed] [Google Scholar]
  • 7.Han J, Zhang X, Jiang J, Li W. 2021. How much of the total organic halogen and developmental toxicity of chlorinated drinking water might be attributed to aromatic halogenated DBPs? Environ Sci Technol 55(9):5906–5916, PMID: , 10.1021/acs.est.0c08565. [DOI] [PubMed] [Google Scholar]
  • 8.Wu Y, Wei W, Luo J, Pan Y, Yang M, Hua M, et al. 2022. Comparative toxicity analyses from different endpoints: are new cyclic disinfection byproducts (DBPs) more toxic than common aliphatic DBPs? Environ Sci Technol 56(1):194–207, PMID: , 10.1021/acs.est.1c03292. [DOI] [PubMed] [Google Scholar]
  • 9.Richardson SD, Plewa MJ, Wagner ED, Schoeny R, DeMarini DM. 2007. Occurrence, genotoxicity, and carcinogenicity of regulated and emerging disinfection by-products in drinking water: a review and roadmap for research. Mutat Res 636(1–3):178–242, PMID: , 10.1016/j.mrrev.2007.09.001. [DOI] [PubMed] [Google Scholar]
  • 10.Zwiener C, Richardson SD, De Marini DM, Grummt T, Glauner T, Frimmel FH. 2007. Drowning in disinfection byproducts? Assessing swimming pool water. Environ Sci Technol 41(2):363–372, PMID: , 10.1021/es062367v. [DOI] [PubMed] [Google Scholar]
  • 11.Becker K, Schulz C, Kaus S, Seiwert M, Seifert B. 2003. German Environmental Survey 1998 (GerES III): environmental pollutants in the urine of the German population. Int J Hyg Environ Health 206(1):15–24, PMID: , 10.1078/1438-4639-00188. [DOI] [PubMed] [Google Scholar]
  • 12.Dufour P, Pirard C, Charlier C. 2017. Determination of phenolic organohalogens in human serum from a Belgian population and assessment of parameters affecting the human contamination. Sci Total Environ 599–600:1856–1866, PMID: , 10.1016/j.scitotenv.2017.05.157. [DOI] [PubMed] [Google Scholar]
  • 13.IARC (International Agency for Research on Cancer). 1999. Re-evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide. Lyon, France: IARC. https://www.ncbi.nlm.nih.gov/books/NBK498701/ [accessed 3 December 2023]. [Google Scholar]
  • 14.Jansson K, Jansson V. 1992. Genotoxicity of 2,4,6-trichlorophenol in V79 Chinese hamster cells. Mutat Res 280(3):175–179, PMID: , 10.1016/0165-1218(92)90046-3. [DOI] [PubMed] [Google Scholar]
  • 15.Barańska A, Woźniak A, Mokra K, Michałowicz J. 2022. Genotoxic mechanism of action of TBBPA, TBBPS and selected bromophenols in human peripheral blood mononuclear cells. Front Immunol 13:869741, PMID: , 10.3389/fimmu.2022.869741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Liu Y, Zhu D, Zhao Z, Zhou Q, Pan Y, Shi W, et al. 2021. Comparative cytotoxicity studies of halophenolic disinfection byproducts using human extended pluripotent stem cells. Chemosphere 263:127899, PMID: , 10.1016/j.chemosphere.2020.127899. [DOI] [PubMed] [Google Scholar]
  • 17.Yang M, Zhang X. 2013. Comparative developmental toxicity of new aromatic halogenated DBPs in a chlorinated saline sewage effluent to the marine polychaete Platynereis dumerilii. Environ Sci Technol 47(19):10868–10876, PMID: , 10.1021/es401841t. [DOI] [PubMed] [Google Scholar]
  • 18.Igbinosa EO, Odjadjare EE, Chigor VN, Igbinosa IH, Emoghene AO, Ekhaise FO, et al. 2013. Toxicological profile of chlorophenols and their derivatives in the environment: the public health perspective. ScientificWorldJournal 2013:460215, PMID: , 10.1155/2013/460215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Xie Y, Jiang L, Qiu J, Wang Y. 2019. A comparative evaluation of the immunotoxicity and immunomodulatory effects on macrophages exposed to aromatic trihalogenated DBPs. Immunopharmacol Immunotoxicol 41(2):319–326, PMID: , 10.1080/08923973.2019.1608444. [DOI] [PubMed] [Google Scholar]
  • 20.Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, et al. 2018. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol 233(9):6425–6440, PMID: , 10.1002/jcp.26429. [DOI] [PubMed] [Google Scholar]
  • 21.Weiss G, Schaible UE. 2015. Macrophage defense mechanisms against intracellular bacteria. Immunol Rev 264(1):182–203, PMID: , 10.1111/imr.12266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Asai A, Tsuda Y, Kobayashi M, Hanafusa T, Herndon DN, Suzuki F. 2010. Pathogenic role of macrophages in intradermal infection of methicillin-resistant Staphylococcus aureus in thermally injured mice. Infect Immun 78(10):4311–4319, PMID: , 10.1128/IAI.00642-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Liu Y, Liu Z, Tang H, Shen Y, Gong Z, Xie N, et al. 2019. The N6-methyladenosine (m6A)-forming enzyme METTL3 facilitates M1 macrophage polarization through the methylation of STAT1 mRNA. Am J Physiol Cell Physiol 317(4):C762–C775, PMID: , 10.1152/ajpcell.00212.2019. [DOI] [PubMed] [Google Scholar]
  • 24.Zheng Q, Hou J, Zhou Y, Li Z, Cao X. 2017. The RNA helicase DDX46 inhibits innate immunity by entrapping m6A-demethylated antiviral transcripts in the nucleus. Nat Immunol 18(10):1094–1103, PMID: , 10.1038/ni.3830. [DOI] [PubMed] [Google Scholar]
  • 25.Yu R, Li Q, Feng Z, Cai L, Xu Q. 2019. M6A reader YTHDF2 regulates LPS-induced inflammatory response. Int J Mol Sci 20(6):1323, PMID: , 10.3390/ijms20061323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Wu C, Chen W, He J, Jin S, Liu Y, Yi Y, et al. 2020. Interplay of m6A and H3K27 trimethylation restrains inflammation during bacterial infection. Sci Adv 6(34):eaba0647, PMID: , 10.1126/sciadv.aba0647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Winkler R, Gillis E, Lasman L, Safra M, Geula S, Soyris C, et al. 2019. m6A modification controls the innate immune response to infection by targeting type I interferons. Nat Immunol 20(2):173–182, PMID: , 10.1038/s41590-018-0275-z. [DOI] [PubMed] [Google Scholar]
  • 28.Batista PJ. 2017. The RNA modification N6-methyladenosine and its implications in human disease. Genomics Proteomics Bioinformatics 15(3):154–163, PMID: , 10.1016/j.gpb.2017.03.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Machnicka MA, Milanowska K, Osman Oglou O, Purta E, Kurkowska M, Olchowik A, et al. 2013. MODOMICS: a database of RNA modification pathways—2013 update. Nucleic Acids Res 41(database issue):D262–D267, PMID: , 10.1093/nar/gks1007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Fu Y, Dominissini D, Rechavi G, He C. 2014. Gene expression regulation mediated through reversible m6A RNA methylation. Nat Rev Genet 15(5):293–306, PMID: , 10.1038/nrg3724. [DOI] [PubMed] [Google Scholar]
  • 31.Yang Y, Hsu PJ, Chen YS, Yang YG. 2018. Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res 28(6):616–624, PMID: , 10.1038/s41422-018-0040-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, et al. 2011. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol 7(12):885–887, PMID: , 10.1038/nchembio.687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Zheng G, Dahl JA, Niu Y, Fedorcsak P, Huang CM, Li CJ, et al. 2013. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell 49(1):18–29, PMID: , 10.1016/j.molcel.2012.10.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Patil DP, Pickering BF, Jaffrey SR. 2018. Reading m6A in the transcriptome: m6A-binding proteins. Trends Cell Biol 28(2):113–127, PMID: , 10.1016/j.tcb.2017.10.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Qi Y, Zhang Y, Zhang J, Wang J, Li Q. 2022. The alteration of N6-methyladenosine (m6A) modification at the transcriptome-wide level in response of heat stress in bovine mammary epithelial cells. BMC Genomics 23(1):829, PMID: , 10.1186/s12864-022-09067-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Xu S, Li Y, Chen JP, Li DZ, Jiang Q, Wu T, et al. 2020. Oxygen glucose deprivation/re-oxygenation-induced neuronal cell death is associated with Lnc-D63785 m6A methylation and miR-422a accumulation. Cell Death Dis 11(9):816, PMID: , 10.1038/s41419-020-03021-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Engel M, Eggert C, Kaplick PM, Eder M, Röh S, Tietze L, et al. 2018. The role of m6A/m-RNA methylation in stress response regulation. Neuron 99(2):389–403e9, PMID: , 10.1016/j.neuron.2018.07.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Cayir A, Barrow TM, Guo L, Byun HM. 2019. Exposure to environmental toxicants reduces global N6-methyladenosine RNA methylation and alters expression of RNA methylation modulator genes. Environ Res 175:228–234, PMID: , 10.1016/j.envres.2019.05.011. [DOI] [PubMed] [Google Scholar]
  • 39.Kupsco A, Gonzalez G, Baker BH, Knox JM, Zheng Y, Wang S, et al. 2020. Associations of smoking and air pollution with peripheral blood RNA N6-methyladenosine in the Beijing Truck Driver Air Pollution Study. Environ Int 144:106021, PMID: , 10.1016/j.envint.2020.106021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Saha C, Mohanraju P, Stubbs A, Dugar G, Hoogstrate Y, Kremers GJ, et al. 2020. Guide-free Cas9 from pathogenic Campylobacter jejuni bacteria causes severe damage to DNA. Sci Adv 6(25):eaaz4849, PMID: , 10.1126/sciadv.aaz4849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Song H, Feng X, Zhang H, Luo Y, Huang J, Lin M, et al. 2019. METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes. Autophagy 15(8):1419–1437, PMID: , 10.1080/15548627.2019.1586246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Dominissini D, Moshitch-Moshkovitz S, Salmon-Divon M, Amariglio N, Rechavi G. 2013. Transcriptome-wide mapping of N6-methyladenosine by m6A-seq based on immunocapturing and massively parallel sequencing. Nat Protoc 8(1):176–189, PMID: , 10.1038/nprot.2012.148. [DOI] [PubMed] [Google Scholar]
  • 43.Cui X, Wei Z, Zhang L, Liu H, Sun L, Zhang SW, et al. 2016. Guitar: an R/bioconductor package for gene annotation guided transcriptomic analysis of RNA-Related genomic features. Biomed Res Int 2016:8367534, PMID: , 10.1155/2016/8367534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Robinson MD, McCarthy DJ, Smyth GK. 2010. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26(1):139–140, PMID: , 10.1093/bioinformatics/btp616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Ruiz-Rosado Jde D, Olguín JE, Juárez-Avelar I, Saavedra R, Terrazas LI, Robledo-Avila FH, et al. 2016. MIF promotes classical activation and conversion of inflammatory Ly6Chigh monocytes into TipDCs during murine toxoplasmosis. Mediators Inflamm 2016:9101762, PMID: , 10.1155/2016/9101762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Neal LM, Knoll LJ. 2014. Toxoplasma gondii profilin promotes recruitment of Ly6Chi CCR2+ inflammatory monocytes that can confer resistance to bacterial infection. PLoS Pathog 10(6):e1004203, PMID: , 10.1371/journal.ppat.1004203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Pappas G, Roussos N, Falagas ME. 2009. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol 39(12):1385–1394, PMID: , 10.1016/j.ijpara.2009.04.003. [DOI] [PubMed] [Google Scholar]
  • 48.Schnapp LM, Geaghan SM, Campagna A, Fahy J, Steiger D, Ng V, et al. 1992. Toxoplasma gondii pneumonitis in patients infected with the human immunodeficiency virus. Arch Intern Med 152(5):1073–1077, PMID: , 10.1001/archinte.152.5.1073. [DOI] [PubMed] [Google Scholar]
  • 49.Fernàndez-Sabé N, Cervera C, Fariñas MC, Bodro M, Muñoz P, Gurguí M, et al. 2012. Risk factors, clinical features, and outcomes of toxoplasmosis in solid-organ transplant recipients: a matched case–control study. Clin Infect Dis 54(3):355–361, PMID: , 10.1093/cid/cir806. [DOI] [PubMed] [Google Scholar]
  • 50.Paquet C, Yudin MH, Society of Obstetricians and Gynaecologists of Canada. 2013. Toxoplasmosis in pregnancy: prevention, screening, and treatment. J Obstet Gynaecol Can 35(1):78–81, PMID: , 10.1016/s1701-2163(15)31053-7. [DOI] [PubMed] [Google Scholar]
  • 51.Saadatnia G, Golkar M. 2012. A review on human toxoplasmosis. Scand J Infect Dis 44(11):805–814, PMID: , 10.3109/00365548.2012.693197. [DOI] [PubMed] [Google Scholar]
  • 52.Ling YM, Shaw MH, Ayala C, Coppens I, Taylor GA, Ferguson DJP, et al. 2006. Vacuolar and plasma membrane stripping and autophagic elimination of Toxoplasma gondii in primed effector macrophages. J Exp Med 203(9):2063–2071, PMID: , 10.1084/jem.20061318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Li Z, Zhao ZJ, Zhu XQ, Ren QS, Nie FF, Gao JM, et al. 2012. Differences in iNOS and arginase expression and activity in the macrophages of rats are responsible for the resistance against T. gondii infection. PLoS One 7(4):e35834, PMID: , 10.1371/journal.pone.0035834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Park J, Hunter CA. 2020. The role of macrophages in protective and pathological responses to Toxoplasma gondii. Parasite Immunol 42(7):e12712, PMID: , 10.1111/pim.12712. [DOI] [PubMed] [Google Scholar]
  • 55.Richardson SD, Fasano F, Ellington JJ, Crumley FG, Buettner KM, Evans JJ, et al. 2008. Occurrence and mammalian cell toxicity of iodinated disinfection byproducts in drinking water. Environ Sci Technol 42(22):8330–8338, PMID: , 10.1021/es801169k. [DOI] [PubMed] [Google Scholar]
  • 56.Pekari K, Luotamo M, Järvisalo J, Lindroos L, Aitio A. 1991. Urinary excretion of chlorinated phenols in saw-mill workers. Int Arch Occup Environ Health 63(1):57–62, PMID: , 10.1007/BF00406199. [DOI] [PubMed] [Google Scholar]
  • 57.Leonetti C, Butt CM, Hoffman K, Miranda ML, Stapleton HM. 2016. Concentrations of polybrominated diphenyl ethers (PBDEs) and 2,4,6-tribromophenol in human placental tissues. Environ Int 88:23–29, PMID: , 10.1016/j.envint.2015.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Jiang X, Shi P, Jiang L, Qiu J, Xu B, Pan Y, et al. 2022. In vivo toxicity evaluations of halophenolic disinfection byproducts in drinking water: a multi-omics analysis of toxic mechanisms. Water Res 218:118431, PMID: , 10.1016/j.watres.2022.118431. [DOI] [PubMed] [Google Scholar]
  • 59.Miao T, Li M, Shao T, Jiang X, Jiang L, Zhou Q, et al. 2022. The involvement of branched-chain amino acids (BCAAs) in aromatic trihalogenated DBP exposure-induced kidney damage in mice. Chemosphere 305:135351, PMID: , 10.1016/j.chemosphere.2022.135351. [DOI] [PubMed] [Google Scholar]
  • 60.Yin X, Liu Y, Zeb R, Chen F, Chen H, Wang KJ. 2020. The intergenerational toxic effects on offspring of medaka fish Oryzias melastigma from parental benzo[a]pyrene exposure via interference of the circadian rhythm. Environ Pollut 267:115437, PMID: , 10.1016/j.envpol.2020.115437. [DOI] [PubMed] [Google Scholar]
  • 61.Niu Y, Zhao X, Wu YS, Li MM, Wang XJ, Yang YG. 2013. N6-methyl-adenosine (m6A) in RNA: an old modification with a novel epigenetic function. Genomics Proteomics Bioinformatics 11(1):8–17, PMID: , 10.1016/j.gpb.2012.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Rujanapun N, Aueviriyavit S, Boonrungsiman S, Rosena A, Phummiratch D, Riolueang S, et al. 2015. Human primary erythroid cells as a more sensitive alternative in vitro hematological model for nanotoxicity studies: toxicological effects of silver nanoparticles. Toxicol In Vitro 29(8):1982–1992, PMID: , 10.1016/j.tiv.2015.08.005. [DOI] [PubMed] [Google Scholar]
  • 63.Bregoli L, Chiarini F, Gambarelli A, Sighinolfi G, Gatti AM, Santi P, et al. 2009. Toxicity of antimony trioxide nanoparticles on human hematopoietic progenitor cells and comparison to cell lines. Toxicology 262(2):121–129, PMID: , 10.1016/j.tox.2009.05.017. [DOI] [PubMed] [Google Scholar]
  • 64.Kermanizadeh A, Brown DM, Stone V. 2019. The variances in cytokine production profiles from non- or activated THP-1, Kupffer cell and human blood derived primary macrophages following exposure to either alcohol or a panel of engineered nanomaterials. PLoS One 14(8):e0220974, PMID: , 10.1371/journal.pone.0220974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Chang HR, Grau GE, Pechère JC. 1990. Role of TNF and IL-1 in infections with Toxoplasma gondii. Immunology 69(1):33–37, PMID: . [PMC free article] [PubMed] [Google Scholar]
  • 66.Ge L, Zhang Y, Zhao X, Wang J, Zhang Y, Wang Q, et al. 2021. EIF2AK2 selectively regulates the gene transcription in immune response and histones associated with systemic lupus erythematosus. Mol Immunol 132:132–141, PMID: , 10.1016/j.molimm.2021.01.030. [DOI] [PubMed] [Google Scholar]
  • 67.Zaccara S, Jaffrey SR. 2020. A unified model for the function of YTHDF proteins in regulating m6A-modified mRNA. Cell 181(7):1582–1595.e18, PMID: , 10.1016/j.cell.2020.05.012. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES